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ABSTRACT 
 
Acute studies have revealed that insulin and possibly incretin hormone [e.g., glucagon-
like peptide-1 (GLP-1)] response in humans is significantly affected by whey protein 
(WP) form [e.g., whey protein isolate (WPI) versus hydrolysate (WPH)], whereas 
extensive hydrolysates of casein protein, versus native casein, were recently shown to 
promote a potentially greater (p=0.10) acute muscle protein synthesis response.  
Similarly, fractions and specific peptides from WP have been identified that may 
potentiate exercise recovery and/or the muscle protein synthesis response from heavy 
resistance training.  However, to date, no study has compared the chronic effects WP 
form or molecular distribution may have when consumed in combination with heavy 
resistance training.  PURPOSE: Therefore, the primary purpose of this investigation was 
to compare the effects of three different variations of a WP on the physiological response 
to weight training in previously resistance trained, healthy males.  METHODS: Fifty-six 
resistance trained men (21.40±0.36 yrs; 79.46±1.04 kg; 178.59±0.66 cm; 1.24±0.03 1RM 
bench press-to-body mass ratio) were randomly assigned to receive one of four double-
blinded treatments: 30 g/serving carbohydrate (PLA) or 30 g/serving protein from either 
a) 80% whey protein concentrate (WPC80), b) high lactoferrin containing 80% WPC 
(WPC80+), or c) extensively hydrolyzed WPC80 (WPH).  All subjects participated in 
eight weeks of a split-body, linear periodized resistance training program, and consumed 
two servings of treatment per day (one immediately pre- and post-exercise on training 
days; twice between meals on non-training days).  Body composition, upper- and lower-
body strength [1RM Bench Press (1RM BP) and 1RM Hack Squat (1RM HS), 
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respectively] and anaerobic endurance [80% of 1RM for maximal repetitions (80RM BP 
and 80RM HS, respectively)], and fasted blood measures were assessed before (PRE) and 
after (POST) the 8-week intervention.  Twenty-four hour muscle damage (CK) and 
immune (WBC) response to lower-body resistance training was assessed during Week 1 
and 8.  Also, total repetitions to failure, CK and WBC were assessed during POST, prior 
to and in response to repeated daily (x3) bouts of 80RM HS.  Two-way repeated 
measures ANCOVAs were used for statistical analyses.  Significance was set at α = 0.05.  
RESULTS: No significant differences (p>0.05) were observed between groups for total 
training volume (kg/min), or relative energy (kcals/kg/d), protein (g/kg/d), carbohydrate 
(g/kg/d), or lipid (g/kg/d) during the 8-week intervention.  All groups increased 
(p<0.0125) 1RM BP (kg), 1RM HS (kg), 80RM BP (reps) and 80RM HS (reps) from 
PRE to POST, however, no significant (p>0.05) between-group effects were observed.  
For repeated 80RM HS tests, only WPC80+ realized a significant difference for total 
repetitions completed between any of the three days of testing (+15.56% more repetitions 
for 80RM24 versus 80RMPOST; p<0.0125).  No significant between- or within-group 
(p>0.05 and p>0.0125, respectively) changes were observed for 12-hour fasted blood 
lipids, glucose, WBC or CK from PRE to POST; however, all groups reduced (p<0.0125) 
creatinine, and WPH creatinine at POST was shown to be significantly different from 
WPC80+ (-14.218%∆; p<0.05).  Urea nitrogen (BUN) was also shown to decrease 
significantly (p<0.0125) from PRE to POST for WPH (-18.064%), which differed 
significantly (p<0.05) from WPC80 (+16.908%; p<0.0125).  CK response to Week 1 
versus Week 8 lower-body exercise, however, decreased significantly in all groups 
except WPH (-60.327%; p=0.073), and no significant differences occurred between- or 
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within-groups for WBC.  Likewise, repeated 80RM HS resulted in no significant between 
group differences (p>0.05) for either CK or WBC.  Lean body mass and total body 
muscle mass increased (p<0.0125) in all groups, as did body mass in all groups except 
WPH (+0.641 kg; p=0.114).  However, WPH realized a significant PRE to POST 
reduction in fat mass (-5.942%) and percent body fat (-1.601%), which was significantly 
different (p<0.05) from PLA (+9.100% and +0.640%, respectively).  CONCLUSION: In 
previously trained, college-aged men, 60 g/d of WPC80, WPC80+, WPH or PLA provide 
similar responses to an 8-week heavy resistance training program on measures of total 
body muscle mass, strength, anaerobic endurance and blood lipids.  However, WPH 
appears to significantly augment lipolysis and may increase nitrogen retention. 
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INTRODUCTION 
 
Resistance exercise, both in the fasted and postprandial state, and protein (PRO) ingestion 
independent of exercise have each been shown to stimulate muscle protein synthesis 
(MPS).(1-3)  However, combined strenuous resistance training or recovery from exercise 
in the presence of increased essential amino acid (EAA) availability has been shown to 
significantly increase exercise-induced MPS and more dramatically affect measures of 
anabolic response and adaptation to training than exercise alone or exercise plus 
carbohydrate.  Carbohydrate (CHO) intake, however, does not appear to directly 
influence MPS, but rather, via insulin, has been shown to act as an antagonist to muscle 
protein breakdown (MPB) but cannot ultimately raise exercise-induced MPS in the 
absence of increased EAA availability.(1-4)  Optimally, when MPS > MPB then net 
protein balance is positive; when repeated chronically over time, the cumulative effect 
can lead to increases in muscle fiber hypertrophy. 
 
Whether PRO should be consumed prior to, following, or both pre- and post-exercise to 
most effectively stimulate chronic changes in muscle hypertrophy and strength is less 
clear.(5)  Acute data indicates that MPS will be significantly elevated so long as 
resistance exercise is performed in the presence of increased EAA availability or 
provision of EAA are made available within 1-2 hours, and not beyond 4-5 hours post-
exercise.(6-8)  Furthermore, Bohe et al. (9) concluded that it is the extracellular 
concentration of EAA rather than intracellular availability that significantly affects MPS.  
Assuming peak EAA concentrations occur between 20-90 minutes post-ingestion of fast-
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absorbing proteins (e.g., whey) (10-13), and exercise duration lasts 45-90 minutes, 
consuming PRO both pre- and post-exercise, as opposed to any one feeding time alone, 
may elicit the most significant effects on resistance training adaptations. 
 
Specifically, the magnitude of myofibrillar protein synthesis arising from acute resistance 
exercise performed under fasted conditions indicates that the response is intensity 
dependent at low training intensities (relative to one-rep maximum, or 1RM), but plateaus 
when training involves 60-90% 1RM loading.  Additionally, myofibrillar protein 
synthesis, regardless of age, appears to return to near baseline levels by 2-4 hours post-
exercise under fasted conditions and thus establishes some basis for the need to increase 
nutrient availability within this optimal post-workout "window."(6)  For example, when 
whey protein isolate (WPI) was provided immediate post-exercise, myofibrillar protein 
synthesis has been reported to remain significantly elevated (+229%) by up to five hours 
post-exercise.(7)  An intriguing finding of the aforementioned Moore et al. (7) study was 
that sarcoplasmic protein synthesis was significantly elevated at three hours post-WPI 
ingestion alone, and was not further increased in response to combined resistance training 
and PRO ingestion.  In myofibrillar protein, a significantly additive response was 
observed beginning at one hour and continuing through five hours post-exercise WPI 
ingestion.  Such a finding would seem to support the hypothesis that chronic PRO 
ingestion at intervals of approximately every 2-3 hours may optimally maintain a positive 
anabolic state. 
 
Tipton et al. (14) concluded that 20 g of whey PRO (WP), consumed either immediately 
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before or one hour following ~25 minutes of heavy, intermittent knee extension training 
at 80% 1RM, in previously inactive, but healthy subjects, resulted in equivocal net 
muscle protein balance; each trial raising arterial AA concentrations by ~50% above 
baseline.  These results may, however, be specific to the population (previously 
untrained), protein source (WP) and/or duration of the fasting period prior to subjects 
receiving the pre-exercise PRO bolus.(15)  Specifically, with regards to population 
training status, acute exercise bouts have been shown to result in a more rapid, but short-
lived rise in MPS in response to training; whereas peak MPS and its decline occurs more 
gradually in previously untrained muscle.  For example, Tang et al. (8) reported that, 
under fasted conditions, a 162% increase in MPS occurred in response to training by four 
hours post-exercise, which was significantly greater (p<0.01) than the 108% rise in MPS 
at the same timepoint in previously untrained.  Furthermore, MPS appeared to peak at 16 
hours post-exercise in previously untrained muscle, whereby MPS under trained 
conditions was not significantly different from baseline at 16 hours post.  By 28 hours 
post-exercise, MPS was still significantly elevated in the untrained group (+70%; 
p<0.01). 
 
In light of the aforementioned data, it is of little surprise that no significant differences 
were observed for pre- versus post-exercise PRO ingestion in the Tipton et al. study (14): 
subjects had not engaged in regular resistance training for at least five years, and PRO 
balance was assessed for only four hours post-exercise.  Thus, the anabolic response to 
combined resistance training and timed PRO ingestion may be more predicative in 
previously trained populations.  For example, Hulmi et al. (16) reported that 15 g of WP, 
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consumed immediately prior to and following twice weekly resistance training in 
previously untrained males, significantly increased acute (1- and 48-hour post exercise) 
and chronic (after 21 weeks) mammalian target of rapamycin (mTOR) signaling response 
versus nonenergetic placebo.  Despite significant increases in mTOR signaling, which 
can stimulate MPS and hypertrophy, type I (slow-twitch) and type II (fast twitch) muscle 
fiber cross-sectional area of the vastus lateralis, as assessed by immunohistochemical 
staining, was no different between WP and placebo.  Body mass and muscle thickness, as 
assessed by ultrasonography, was however significantly greater in the WP group by 10.5 
weeks and again after 21 weeks.  Non-energetic placebo plus exercise resulted in only a 
statistically significant within-group change in muscle thickness which was not 
significantly different from non-exercise control.  In response to 10 weeks combined 
heavy resistance training (4 d/wk x 6-8 reps/set x 3 sets @ 85-90% 1RM) and 20g PRO 
or CHO supplementation consumed one hour prior to and following exercise, in 
previously untrained men, Willoughby et al. (17) did, however, report greater gains in 
markers of MPS, anabolism and performance from PRO.  In resistance-trained subjects, 
Kerksick et al. (18) reported that 48 g/d of a PRO blend consisting of WP (40 g/d) and 
casein (CP; 8 g/d), versus a blend of WP (40 g/d), branched chain amino acids (BCAA; 3 
g/d) and glutamine (5 g/d), or 48 g/d CHO, resulted in the most significant improvements 
on body composition following a similar 10-wk training program as was used in the 
aforementioned Willoughby et al. (17) study.  Changes in maximal upper- and lower-
body strength and anaerobic capacity were, however, equal amongst groups in the 
Kerksick et al. trial.  It appears then, from the above studies, that, 1) combined strenuous 
resistance training and WP supplementation differentially affects the physiological 
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benefits observed in trained versus untrained males (i.e., metabolic adaptations may be 
more affected in trained subjects, whereas the response in untrained may be more global), 
and 2) PRO source appears to influence physiological response (e.g., higher total dose of 
native PRO was more effective than partial substitution with free amino acids). 
 
To further elaborate on the potential contribution of PRO source on physiological 
adaptations to resistance exercise, Cribb and colleagues (19) provided evidence that 1.5 
g/kg b.w./d x 10 wks of whey protein hydrolysate (WPH; as derived from WPI) increased 
fat-free mass (FFM), reduced fat mass (FM), and resulted in significantly greater 
(p<0.05) gains in absolute and relative strength in recreational bodybuilders, when 
compared to consuming an hydrolysate of CP (CPH).  Similarly, Tang et al. (20) recently 
reported that, in healthy but untrained males, an acute dose of 10 g of EAA from WPH 
increased MPS significantly more than an equivalent dose of EAA from soy protein 
isolate (SPI) or CP at rest (+18% and +93%, respectively) and in response to resistance 
exercise (+31% and +122%, respectively).  Blood EAA, total BCAA and leucine 
concentrations were also significantly higher in response to WPH.  One limitation to the 
study, however, was that WP quality [using WPH as opposed to a native whey protein 
concentrate (WPC) or WPI] may have been a significant contributing factor in eliciting 
the improved effects when compared to native CP or SPI.  For example, Tipton et al. (21) 
found no significant differences in net phenylalanine balance for up to five hrs post-
exercise in response to consuming 20 g of either CP or WPI one hour after exercise, in 
healthy but untrained men and women.  The WPI did, however, result in significantly 
higher peak and total area under the curve for insulin, intracellular leucine concentrations, 
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and net leucine balance, compared to CP and placebo.  Eighteen grams of milk protein 
isolate (MPI; a mixture of 20% WP and 80% CP) did, however, significantly increase 
MPS and total area under the curve for net protein balance when consumed immediately 
post-exercise and compared to the effects of 18 g SPI in healthy, young male 
subjects.(22)  Anabolic superiority of dairy protein over soy was not observed, however, 
when compared on a macro physiological level in response to six weeks of combined 
resistance training and PRO supplementation.(23)  Candow et al. (23) concluded that 
both WP and SP provided comparable improvements above exercise alone, and that these 
results were independent of PRO source.  Two methodological concerns arise in 
interpreting the findings of this study, though: 1) 18 female and 9 male subjects were 
divided across three groups which may confound sex specific responses and statistical 
power, and 2) study duration may have been too abbreviated to observe mean differences 
between groups of such a small sample size.  It has also been reported that SP 
preferentially increases splanchic protein synthesis as opposed to peripheral tissue protein 
synthesis (e.g., MPS), and that conversion to urea is greater for soy than from dairy.(24, 
25)  Exceptions notwithstanding, it appears then that dairy protein, and possibly WPH in 
particular may elicit the most profound effect on MPS and EAA availability; most 
probably during acute feeding or in response to heavy resistance training.  If true, the 
combination of effects may improve chronic adaptations to exercise. 
 
No data, however, is available to directly assess the chronic impact of combined 
resistance training and WP form or molecular composition.  Instead, hypothetical 
extrapolation from sparse acute observations involving WP and other PRO sources is 
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currently necessary.  From work involving acute bouts of high-intensity resistance 
exercise in trained, healthy men, and employing a 4-hour primed constant infusion (of 
radiolabeled l-leucine), Moore et al. (26) revealed, for example, a curvilinear rise in MPS 
from immediate post-exercise ingestion of 0, 5, 10, 20 and 40 g of egg albumin PRO.  
MPS increased under fasting conditions (0 g PRO) and was approximately 37%, 56% and 
93% greater than the fasted response for 5, 10 and 20 g PRO trials, respectively.  The rise 
in MPS from 20 to 40 g was not significantly different and there was no significant 
effect, at any PRO dose, on downstream signaling proteins of mTOR, insulin or glucose 
concentrations over time.  Therefore, collectively supporting the widely held conclusion 
that stimulation of MPS is most affected by EAA availability, independent of insulin or 
glucose.  Cuthbertson et al. (27) came to a similar conclusion when comparing the effects 
of consuming a 0, 2.5, 5, 10, or 20 g EAA solution in healthy young versus elderly men 
after a 12-hour fast.  Here, insulin and growth hormone were both clamped to maintain 
baseline plasma insulin concentrations (~10 mIU/L) throughout the 4-hour duration and 
across all EAA doses.  Again, a dose-dependent rise as well as a ceiling effect was 
observed in the ability to stimulate MPS.  Specifically, a dose-dependent increase in 
myofibrillar protein synthesis was observed up to 10 g, and was not significantly different 
for 10 versus 20 g ingested EAA in the younger males.  Sarcoplasmic protein synthesis 
followed the same pattern, but to a lesser extent.  The patterns observed in the elderly 
subjects yielded similar curvilinear slopes, albeit shifted down and to the right; indicative 
of decreased MPS stimulatory sensitivity and responsiveness with aging.  The lack of an 
insulinotropic response to PRO ingestion as well as the lower relative changes in MPS 
observed by Moore et al. (26) may likely be the result of PRO source and/or quality.  For 
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example, Koopman et al. (13) showed that CPH was significantly more effective than 
intact CP at increasing insulin and MPS response, as well as increasing plasma AA 
concentrations.  Deglaire et al. (28), however, recently showed otherwise.  CPH indeed 
resulted in a faster rate of absorption, eliciting both an earlier and stronger rise in plasma 
insulin and AA concentrations, but there was no significant difference between CP and 
CPH for whole-body nitrogen retention.  Power et al. (11), however, presented evidence 
that ingestion of 45 g WPH provides a significantly higher and total (as measured by area 
under the curve) insulin response when compared to consuming an equal dose of WPI.  In 
fact, Claessens et al. (29) showed that both plasma insulin and glucagon rises, and 
glucose falls in a dose-dependent (0.3 to 0.6 g/kg b.w.) fashion for WPI, SPI and their 
extensively hydrolyzed proteins (WPH and SPH, respectively) in healthy, fasted males.  
However, no such dose-dependent effect on glucose response was observed for SPI and 
dose-dependent flux across all proteins and doses tested was most profound for glucagon.  
Interestingly, SPI resulted in higher total area under the curve responses for both insulin 
and glucagon compared to SPH, whereas no significant differences were noted between 
WPI and WPH.  The latter may be due to the high concentration of insulinotropic BCAAs 
present in WPI, though.  In vitro and in situ data, for example, revealed that of the seven 
identified BCAA-containing dipeptides isolated (by extensive hydrolysis) from WP, all 
of the identified dipeptides caused significant uptake of glucose into myotubes.  The 
principle BCAA dipeptide present in WPH, Isoleucine-Leucine, also was shown to 
stimulate glucose uptake into, and increase glycogen content in isolated skeletal 
muscle.(30)  Similarly, when a 9.3 g PRO/L solution containing either 80% whey protein 
concentrate (WPC80) or CP, or their respective hydrolysates (WPH and CPH), was 
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consumed in random cross-over fashion by healthy male volunteers after an overnight 
fast, the hydrolysates resulted in 50% greater gastric secretions than their native PRO 
counterparts.  Directly in support of the insulinotropic response of hydrolysates versus 
intact PRO, hydrolysates significantly increased glucose-dependent insulinotropic 
polipeptide (GIP) secretion within the first 20 minutes of gastric emptying.  GIP, as its 
name suggests, stimulates insulin release.  Despite no significant differences for rate of 
gastric emptying, there was an observed faster rate of appearance and peak concentration 
for BCAA, EAA and total amino acids from hydrolysates.  Specifically, concentrations 
peaked at about 20 minutes post-prandial, but only the concentrations for CPH versus CP 
reached significance.(10) 
 
Of note, Claessens et al. (12) reported that hydrolyzed protein from pea, rice, soy, gluten, 
whey or egg all provide significant increases, but not significantly different effects (with 
only one exception) on plasma concentrations of insulin and glucagon response in 
overnight fasted, healthy but sedentary adult males.  Of specific attention in the methods, 
however, is that the degree of hydrolysis (DH) across all PRO sources reportedly varied 
by 9 to 27%, which has been shown to have a significant effect on absorption kinetics 
due to the molecular weight distribution of the resulting PRO fractions.(31, 32)  
Controlling for total PRO concentration, but unfortunately not DH, Foltz et al. (33) 
reported greater stimulation of receptors involved in controlling satiety in vitro: 
hydrolysates of soy>potato>casein, whereas WPH and pea protein hydrolysates were 
ineffective.  In young men provided 50 g of WPI, SPI or egg albumen one hour prior to a 
meal, researchers found that only WPI and SPI significantly reduced total energy intake 
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in the subsequent meal.  This effect wasn't maintained, however, when the treatment 
occurred late in the morning (~1100h) as opposed to early (~900h) – when the treatment 
was conducted in the late morning hours, both SPI and egg increased subsequent meal 
energy intake.  Replacing 25 g of SPI with 25 g of a low or high glycemic CHO (amylose 
or glucose, respectively) also ameliorated the suppression of subsequent meal energy 
intake from SPI preloading.  And lastly, when 50 g of WPI was compared to 50 g of its 
hydrolysate (WPH), duration of satiety was extended by 50%.(34)  These results support 
findings observed in rodents (35) fed an ad libitum diet consisting of 55% of total energy 
from WPI, WPC or milk protein concentrate (MPC) for 25 days.  It was determined that 
WPI>WPC>MPC decreased energy intake and bodyweight gain, with WPI providing the 
most significant energy efficiency (weight gain / energy intake).  Fasting blood lipids, 
insulin and fat mass were also significantly lower for WPI than for the other groups 
(WPI>WPC>MPC).  The importance of these seemingly tangential observations is that, 
again, the speed at which AA enter the small intestine and can increase extracellular AA 
concentrations appears to have widespread effects on a number of physiological 
outcomes with specific application to changes in body composition and, potentially, 
exercise recovery. 
 
Amino acids and PRO are in fact amongst the most potent secretagogues within the 
gastrointestinal tract.  The faster their (AA) rate of appearance into the small intestine and 
at the brush-border membrane, the more profound the response that could be expected 
from an increase in nitrogen or peptide availability.  Extensively hydrolyzed proteins – 
characterized as the majority (>80%) of PRO fractions as ≤1 kD molecular weight, or 
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typically equal to or less than ~8 AA in length – would theoretically provide the greatest 
benefit toward improved rate of availability and increased nitrogen retention.  However, 
very little evidence has directly assessed this research question in humans.  Calbet and 
Holst (10) indeed reported significantly faster rises in plasma AA concentrations from 
CPH as opposed to intact CP, yet no significant effect was observed from WPH versus 
WPI though the slope of their respective absorption curves tend to support the faster 
absorption of AA from hydrolysates.  The average peptide length reported for the 
hydrolysates used in the Calbet and Holst trial was extremely well controlled across both 
hydrolysates and reported to be an average of 3.8 AA in length.  Using direct gastric 
infusion into the small intestine of male volunteers, Grimble et al. (36) reported that low 
molecular weight versus high (M.W.) significantly increased absorption and retention.  
Nitrogen retention in starved rats re-fed WP or CP versus their respective hydrolysates 
have also shown significant benefit from hydrolysates.(37)  However, in the 
aforementioned study, PRO fraction average molecular weight varied greatly between 
hydrolysates.  PRO hydrolysates with the greatest concentration of PRO fractions 
occurring between 0.2-5 kDa have also been reported to increase plasma concentrations 
of AA, nitrogen retention and PRO efficiency, when compared to providing free AA to 
starved rats.(38)  However, AA profile of the two diets was not controlled, but rather only 
total energy from PRO.  In vitro evidence to determine the most hypoallergenic PRO 
formulas for use in non-breast fed infants or in persons with dairy allergies has similarly 
concluded that providing peptides of <1.4 kD results in minimal antigen binding; below 
0.97 kD resulted in no antigen binding.(39)  Such findings highlight the importance of the 
H+-oligopeptide cotransporter, Pept-1, specific to the absorption of di- and tri-peptides 
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(note: Pept-2 transporters are also present within the body, and both Pept-1 and Pept-2 
are active beyond intestinal absorption of AA; however, such a discussion is beyond the 
scope of this paper).  These transporters, located predominantly on the brush-border 
membrane of the intestinal mucosa and basolateral membrane have been reported to 
transport some 400 known dipeptides and 8,000 tripeptides (40), and have become major 
areas of focus in drug discovery and delivery because of the Pept-1 transporter's high 
capacity and low substrate specificity.(40-42)  This contrasts greatly to the low capacity, 
high substrate specificity for uptake of free amino acids.  In fact, bioactive peptides 
derived from hydrolyzed dairy PRO may hold great promise for a number of metabolic 
conditions, such as Type 2 diabetes or insulin-resistance, as well as metabolic wasting 
diseases and aging.  For example, the in vitro and in situ data presented previously (30) 
and involving BCAA-containing dipeptides derived from WPH, may have application in 
diseases affecting glucose metabolism.  Similarly, in human patients with advanced HIV-
infection, 45 g/d WPH significantly increased glutathione levels by two weeks and 
remained significantly elevated after six months of chronic ingestion.  Also of note, body 
weight, T-cell counts and other clinical measures did not deteriorate or change over the 
six-month intervention.(43)  In another group of HIV-positive subjects (44), 40 g WPI x 
2/d x 12 weeks resulted in no change in body mass and significantly increased immune 
response (as characterized by a increase in CD4 lymphocytes), and reduced fasting 
triglycerides.  An isocalorically matched CHO solution, on the other hand, significantly 
reduced CD4 lymphocytes and increased cardiovascular risk factors by raising 
triglycerides.  Whey PRO and WPH, as well as specific bioactive peptides from WP and 
WPH have also been reported to increase free radical scavenging and antioxidant 
13 
 
capacity (45-48), function as angiotensin I-converting enzyme (ACE) inhibitors and 
antihypertensives (49), aid in the treatment of diarrhea, thrombosis, mineral 
malabsorption, immunodeficiency, and function as antimicrobials (50) as well as having 
been shown to increase glutathione response in sedentary and trained male subjects.(51)  
For example, Mulder and colleagues (48) reported that 200 mg/d x 7d, but not 100 mg/d 
of lactoferrin (isolated from whey) significantly increased total T-cell activation and 
antioxidant capacity in 30-55 year old, healthy male subjects.  Therefore, increased 
provision of extensively hydrolyzed WP (WPH) or a high lactoferrin containing WPC, in 
combination with strenuous resistance training, may significantly improve workout 
recovery and facilitate more dramatic physiological adaptations in response to exercise. 
 
To date, however, no studies have compared the chronic effects of different forms of 
WPC (e.g., extensively hydrolyzed WPC versus its native WPC source, or comparison of 
two forms of WPC) for maximizing physiological adaptation to heavy resistance exercise 
in previously trained subjects.  Therefore, the primary purpose of this investigation was 
to compare the effects of heavy resistance exercise plus an extensively hydrolyzed 80% 
WPC (WPH) versus its native WPC80, on body composition, muscle mass, upper- and 
lower-body strength and anaerobic endurance, and clinical measures of exercise recovery 
and adaptation in previously trained, healthy males.  A second purpose of this 
investigation was to compare the effects of WP of different macro-fractional 
concentrations [WPC80 versus WPH versus a high-lactoferrin containing WPC80 
produced by a different WP supplier (WPC80+)], on the physiological response to heavy 
resistance training. 
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PURPOSE 
The primary purpose of this investigation was to evaluate the physiological effects of 
eight weeks of linear, periodized resistance training in combination with 60 g/d (30 g x 
2/d) of one of three forms of whey protein – 80% whey protein concentrate (WPC80), an 
extensively hydrolyzed form of the WPC80 (WPH), and a high-lactoferrin containing 
80% whey protein concentrate from another raw material supplier (WPC80+) – to assess 
the effects of WP quality (as defined by average molecular weight distribution) and 
macro-fraction concentration on body composition, human performance and health in 
previously trained males.  The dependant variables under investigation included body 
composition (BC), muscle mass (MM), upper- and lower-body strength (1RM), upper- 
and lower-body anaerobic endurance (80RM to failure), repeated lower-body 80RM 
bouts, and clinical response and physiological adaptations as determined by blood and 
plasma analyses. 
 
A secondary purpose of this investigation was to quantitatively assess the validity of 
hypotheses that have been proposed in response to acute muscle protein synthesis (MPS) 
and WP data.  That is, do the statistically significant differences that have been observed 
under acute conditions summate into statistically significant effects over time?  Lastly, on 
a consumer level, WPC is the most widely used WP in sports nutrition, largely due to its 
affordable cost.  However, WP substantiation derives predominantly from studies 
involving WPI or WPH.  Thus, a third purpose of this study was to quantify the target 
consumer benefit of consuming WPC versus WPH, versus a carbohydrate placebo (PLA). 
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To simulate real world application, this study involved a minimal nutrition intervention, 
ad libitum diet and was conducted on healthy, college-aged males with a minimum of 
three months uninterrupted bodybuilding and/or strength training experience. 
 
RESEARCH QUESTIONS 
 Does supplementation with WP of predominantly low molecular weight peptides 
(WPH) improve BC, MM, 1RM and 80RM more than native WPC80 or 
WPC80+, when consumed in combination with eight weeks of heavy resistance 
training? 
 Does supplementation with WP of predominantly low molecular weight peptides 
(WPH) improve clinical response to training, as measured by blood and plasma 
analytes, more than WPC80 or WPC80+? 
 Does WP macro-fraction concentration (WPC80 versus WPC80+ versus WPH) 
differentially affect the physiological response to eight weeks of heavy resistance 
training? 
 Does WP supplementation, in combination with eight weeks of heavy resistance 
training, improve BC, MM, 1RM and 80RM more than PLA? 
 Does WP supplementation improve clinical response to training, as measured by 
blood and plasma analytes, more than PLA? 
 
HYPOTHESES TESTED 
 H0: WP supplementation provides no additional benefit to a linear, periodized 
resistance training program in previously trained men (WPH = WPC80 = 
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WPC80+ = PLA). 
 HA1: WP supplementation enhances the effects of resistance exercise by reducing 
FM and %FAT more than PLA, and further increases TBMM, as well as 
improves 1RM, 80RM, repeated 80RM, and clinical adaptations to training (WPH 
= WPC80 = WPC80+  > PLA). 
 HA2: WPH and WPC80+ supplementation enhances the effects of resistance 
exercise by reducing FM and %FAT more than WPC80 or PLA, and further 
increases TBMM, 1RM, 80RM, repeated 80RM, and clinical adaptations to 
training (WPH = WPC80+ > WPC80 > PLA). 
 HA3: WPH augments the physiological response to heavy resistance exercise 
observed by native WP (WPC80 and WPC80+) versus PLA (WPH > WPC80+ = 
WPC80 > PLA). 
 
DELIMITATIONS 
 68 healthy, college-aged (18-35) males were accepted into the study. 
 Qualified participants possessed a minimum of three months uninterrupted, 
chronic (≥3 d/wk) bodybuilding and/or strength training experience. 
 The study duration lasted approximately 10 weeks, consisting of two weeks 
baseline and post-testing (PRE and POST, respectively) and eight weeks of heavy 
resistance training. 
 Subjects participated in 4 d/wk, supervised heavy resistance training using an 
individualized, split-body, linear, periodized program previously shown to elicit 
improvements in body composition and strength in previously trained men.(18) 
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 Participants were recruited from the general public using fliers and direct 
recruitment (e.g., announcements in class and to university fraternities). 
 Participants abstained from consuming ergogenic aids within two weeks 
preceding baseline testing. 
 All participants were required to complete a health history questionnaire and sign 
an informed consent prior to testing. 
 Testing took place within the Human Performance Laboratory, in the Department 
of Health and Exercise Science at the University of Oklahoma (Norman, OK), and 
all blood and serum analyses were conducted by Diagnostic Labs of Oklahoma 
(Oklahoma City, OK). 
 All training sessions were directly supervised, total training volume (load x reps x 
sets) and duration were recorded by subjects, and subjects' weekly training loads 
were prescribed by the study coordinator based upon subject progress. 
 Supplement and placebo servings were double-blinded for packaging, taste, 
texture, solubility in water, and visual characteristics, and individually packaged 
in single serving foil packets.  Each subject was randomly assigned an individual 
case (124 servings) of their randomly assigned group supplement, from which all 
of the subject's servings were pulled. 
 Supplement and placebo ingestion was distributed and supervised by investigators 
on training days (4 x/wk).  Between training sessions, subjects were required to 
consume two packets per day and were only provided enough individually 
marked packets to last until the next scheduled training session. 
 All participants were required to maintain pre-testing dietary habits, and were 
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additionally required to provide three-day nutrition diaries prior to (PRE) and 
during weeks 1, 4-5, and 8 of the study. 
 Dependant Variables measured included: 
o Body Mass (BM) was estimated by electronic clinical scale, and fat mass 
(FM), percent body fat (%FAT) and lean body mass (LBM) were 
estimated by dual-energy X-ray absorptiometry (DXA). 
o Total body muscle mass (TBMM) was estimated using the validated 
DXA-derived prediction equation by Kim et al.(52) 
o Upper- and lower-body strength were determined from one-repetition 
maximum (1RM) testing on the barbell flat bench press (BP) and plate-
loaded incline hack squat machine (HS), respectively. 
o Upper- and lower-body anaerobic endurance were determined from 80% 
1RM repetitions to volitional failure (80RM) on the BP and HS, 
respectively. 
o Twenty-four- and 48-hour repeated lower-body anaerobic endurance 
(80RM, 80RM24 and 80RM48, respectively) was measured on the HS. 
o Clinical adaptations and response to supplementation and heavy resistance 
training were determined from blood and serum assays. 
o Nutritional analysis were determined from three-day (x4) nutrition diaries. 
 
LIMITATIONS 
 Study lacked a genuine random sample [i.e., predominance of undergraduate, 
Caucasian, fraternity members and University of Oklahoma (Norman) students]. 
19 
 
 Limited control over subject compliance to all requirements (e.g., prior resistance 
training experience, health status, use of antibiotics, ergogenic aids, anabolic 
steroids, supplemental exercise between training sessions, maintenance of pre-test 
dietary habits, etc.). 
 Dependence upon subject accuracy for providing reliable dietary recall diaries. 
 Subject withdrawal or removal rate was 16.2%, with 72.7% of all subject drop-
outs (or removals) occurring by the end of the first week of the intervention. 
 Dependence upon DXA as the sole measure to assess changes in body 
composition.(53) 
 Mechanical malfunctioning, during the course of the eight-week intervention, of 
the HS machines used to train and assess lower-body 1RM, 80RM and repeated 
80RM. 
 Did not control for post-exercise nutrition intake beyond delivery of the post-
workout supplement. 
 
ASSUMPTIONS 
Theoretical: 
 Participants answered all recruiting information and health history questionnaire 
questions honestly. 
 Participants observed a 12-hour fast prior to PRE and POST body composition 
testing and blood draws. 
 Participants observed a 4-hour fast prior to week 1 and 8 blood draws. 
 Participants consumed a nearly identical meal, 90-120 minutes prior to both PRE 
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and POST strength and anaerobic endurance tests, as well as prior to 24- and 48-
hr repeated anaerobic endurance tests. 
 Participants did not consume ergogenic aids prior to testing or at any time during 
the eight-week intervention; nor did subjects engage in any supplemental exercise 
outside of regularly scheduled training sessions. 
 Participants did not deviate significantly from pre-study dietary habits, nor did 
subjects use the twice daily shakes to replace regularly scheduled meals. 
 Participants reported any and all adverse events to the investigators. 
 Subjects provided maximal effort on all PRE, POST and repeated exercise tests. 
 Subjects provided maximal effort on all exercise sets during the eight-week 
resistance training intervention. 
 Participants were compliant with the supplementation intervention on non-
training days. 
 The four supplement interventions remained blinded to both the subjects and 
investigators until the study was complete and the statistical analyses had been 
conducted. 
 Equal verbal encouragement and motivation were provided to all participants 
during testing and throughout the eight-week resistance training intervention. 
Statistical: 
 The population from which the subjects were drawn was normally distributed, and 
the data parametric (interval or ratio). 
 The assignment to treatment group was random and the observations obtained are 
independent. 
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 The variability of means between groups were equal or nearly so (homogeneity of 
variance). 
 The correlations between trials were equal or nearly so (homogeneity of 
covariance, or sphericity). 
 Selected covariates used for ANCOVA analysis share a linear relationship with 
the dependent variables (linearity). 
 
STUDY IMPLICATIONS 
Whey protein concentrates (WPC; 34-80% protein per total weight) are the most readily 
used form of WP in sports nutrition products, largely because of their inexpensive cost 
compared to whey protein isolates (WPI; ≥90% protein per total weight) and hydrolysates 
(WPH).  Generally speaking, the lower the percent PRO per total weight, the lower the 
price of the PRO and the higher the CHO and fat content.  Similarly, the lower the 
percent PRO per total weight, the sweeter and more flavorful the taste of the WP.  
Therefore, it should be of little surprise that to attract the greatest number of customers, 
and to do so at the lowest possible cost to remain competitive, has created a commercial 
environment in which the WP market is one dominated by WPC; many times, existing as 
the first PRO ingredient within a host of other proteins and amino acids as part of a 
company’s “proprietary protein blend.”  Paradoxically, structure/function claims used to 
market the majority of WP products available to consumers utilize data derived almost 
exclusively from studies that have involved WPI or WPH within the methods.  Thus, one 
implication of this study is that the differences between chronic supplementation of a 
predominantly low versus high molecular weight WP (WPH vs. WPC, respectively) has 
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been quantified within the target consumer demographic – college-aged males involved 
in bodybuilding and/or strength training exercise.  Secondly, results from this chronic 
study help elucidate hypotheses that have arisen from acute studies reporting significant 
transient differences in anabolic response to hydrolysates versus ingestion of the native 
PRO, in combination with resistance training.  Specifically, data from acute studies 
would indicate that chronic ingestion of WPH may result in more significant increases in 
protein accretion and muscle cross-sectional area over time.  Additionally, this study 
addressed the question of whether different effects are elicited by supplementing with 
different brands of WP of similar PRO concentration (i.e., WPC80 versus WPC80+).  
Lastly, this study adds to the body of literature specific to the efficacy and safety of WP 
supplementation when combined with exercise. 
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REVIEW OF LITERATURE 
 
It has generally been reported that acute protein (PRO) ingestion significantly increases 
muscle protein synthesis (MPS) and provides an augmented anabolic response when 
consumed in combination with strenuous resistance exercise.(1-3)  For example, Dreyer 
et al. (54) reported that acute heavy resistance exercise alone increased MPS by 41% 
above baseline levels, whereas a 145% increase in MPS was observed when a leucine-
rich essential amino acid (EAA) solution was consumed immediately post-exercise.  It 
has not been concluded, however, as to whether consuming PRO prior to, following, or 
when consumed both pre- and post-exercise is most effective at stimulating chronic 
changes in muscle hypertrophy and strength.(5)  Hypotheses generated from acute data 
indicate that MPS will be significantly elevated so long as resistance exercise is 
performed in the presence of increased EAA availability or provision of EAA are made 
available within 1-2 hours, but not greater than 4-5 hours post-exercise.(6-8)  Assuming 
peak AA concentrations occur between 20-90 minutes post-ingestion of fast-absorbing 
PRO (e.g., whey) (10-13), and exercise duration lasts 45-90 minutes, consuming PRO 
both pre- and post-exercise, as opposed to any one feeding time alone, may elicit more 
significant effects on resistance training adaptations. 
 
Results such as those reported by Dreyer et al. (54) are of little surprise then, considering 
that in the post-exercise state insulin sensitivity is increased and there is an increased 
concentration of the major glucose transporter, glucose transporter type-4 (GLUT4), 
present in skeletal muscle membranes.  Therefore, simultaneously eliciting a rise in 
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insulin and increasing AA availability decreases proteolysis and further increases MPS as 
gluconeogenic pathways are inhibited by increased glucose (exogenous or hepatic) 
uptake into muscle.  Whey PRO (WP) and hydrolysates have each been shown to 
stimulate insulin release in the absence of glucose, and MPS may also be upregulated via 
direct anabolic signaling by the essential and branched-chain amino acid (BCAA), 
leucine.(10, 55, 56)  Whether or not leucine, which is present in high concentrations in 
WP, functions in such a capacity is yet to be determined.  Collectively, the data involving 
MPS concludes that it is EAA availability, not glucose, that potentiates the anabolic 
response to exercise.(1, 57)  Furthermore, Bohe et al. (9) concluded that it is the 
extracellular concentration of EAA rather than intracellular EAA availability that 
significantly affects MPS.  Additionally, a curvilinear relationship between PRO 
ingestion and MPS response appears to exist, such that a threshold dose of PRO has been 
postulated to occur at the equivalent of between 8.5-20 g of EAA.(26, 27) 
 
Hypothetically then, combining heavy resistance exercise and its recovery period with 
ingestion of a fast absorbing, insulinotropic PRO source, such as an extensively 
hydrolyzed whey protein (WPH), may augment the exercise-induced MPS response more 
than either carbohydrate (CHO) alone or slower absorbing PRO sources.  As evidence, 
Tang et al. (20) found that when the equivalent of 10 g EAA from either WPH (dairy-
fast), soy protein isolate (SPI; vegetable-fast) or micellar casein (CAS; dairy-slow) were 
consumed immediately post-resistance exercise, that WPH>SPI>CAS stimulated MPS to 
in both trained (post-exercise) and untrained (rest) legs.  From this and similar such acute 
studies, dairy proteins, and possibly WP in particular has largely been accepted as 
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providing the most anabolic response in combination with heavy resistance exercise.(3, 4, 
58, 59) 
 
Comparative studies between the various forms of WP (concentrates, isolates, and 
hydrolysates), however, leaves many research questions unanswered.  Power et al. (11), 
for example, showed that under fasting conditions consumption of ~45 g of WPH peaked 
insulin concentrations higher than an equal dose of whey protein isolate (WPI) in healthy 
male subjects.  A 28% and 43% greater peak and area under the curve for insulin 
response from WPH, respectively, coincided with a 15% lower area under the curve for 
plasma BCAAs which may be indicative of more rapid uptake of BCAAs into myocytes.  
However, no significant differences existed between WPH and WPI for rates of 
appearance for any of the plasma AA investigated.  Casein hydrolysates (CPH), on the 
other hand, have more consistently been shown to increase the rate of AA absorption and 
appearance when compared to intact CAS.(10, 13)  For example, Koopman et al.(13) 
recently reported that, in elderly men, 35 g of CPH significantly increased PRO digestion, 
absorption, insulin response and plasma AA availability, and resulted in a trend (p=0.10) 
toward increased MPS, versus an equal dose of CAS when measured over a 6-hour 
postprandial period.  A plausible explanation for the significant differences observed 
between native CAS and its hydrolysates, versus WP and its hydrolysates, may simply 
have to do with native WP already possessing a rapid rate of absorption. 
 
Extensively hydrolyzed proteins – characterized as the majority (>80%) of PRO fractions 
as ≤1 kD molecular weight, or typically less than about eight AA in length – may 
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theoretically provide improved rates of EAA availability to support increased nitrogen 
retention, compared to native PRO.  However, very little evidence has directly assessed 
this research question in humans.  Calbet and Holst (10) indeed reported significantly 
faster rises in plasma AA concentrations from CPH as opposed to intact CP, yet no 
significant effect was observed for WPH versus WPI.  However, the slopes of the WP 
absorption curves tend to support the faster absorption of AA from hydrolysates.  Using 
direct gastric infusion into the small intestine of male volunteers, Grimble et al. (36) 
reported that low molecular weight PRO fractions (55% of fractions as <4 AA in length) 
significantly increased AA and nitrogen absorption, compared to larger fractions (98% of 
fractions as >4 AA in length), and nitrogen retention in previously starved rats that were 
re-fed WP or CP or their respective hydrolysates has also shown significant benefit from 
hydrolysates.(37)  Such findings appear to highlight the importance of the H+-
oligopeptide cotransporter, Pept-1, specific to the absorption of di- and tri-peptides.  
These transporters, located predominantly on the brush-border membrane of the intestinal 
mucosa and basolateral membrane have been reported to transport some 400 known 
dipeptides and 8,000 tripeptides (40), and have become a major area of focus in drug 
discovery and delivery because of the Pept-1 transporter's high capacity and low substrate 
specificity.(40-42)  This contrasts greatly to the low capacity, high substrate specificity 
for uptake of free amino acids.  In fact, bioactive peptides derived from hydrolyzed dairy 
PRO appear to hold great promise for a number of metabolic conditions, such as Type 2 
diabetes, insulin-resistance, or metabolic wasting diseases and aging.  For example, WP 
and WPH, as well as specific bioactive peptides and PRO fractions from WP and WPH 
have been reported to increase free radical scavenging and antioxidant capacity (45-47), 
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function as angiotensin I-converting enzyme (ACE) inhibitors and antihypertensives (49), 
aid in the treatment of diarrhea, thrombosis, mineral malabsorption, immunodeficiency, 
and function as antimicrobials and antibacterials (50, 60) as well as having been shown to 
increase glutathione response in sedentary and trained male subjects.(51)  Therefore, 
increased provision of extensively hydrolyzed WP (WPH), in combination with strenuous 
resistance training, may significantly improve workout recovery and facilitate more 
dramatic physiological adaptations in response to exercise.  However, large PRO 
fractions, though apparently not absorbed as readily as low molecular weight fractions, 
may instead serve other supporting roles to speed tissue repair and promote improved 
physiological adaptations to exercise.  For example, in vitro and in vivo evidence in 
osteoblast cell cultures and in mice, respectively, have shown the iron-chelating WP 
macro-fraction, lactoferrin, to promote significant osteogenic responses, which may have 
specific application for use in the elderly and female athletes, as well as reducing wound-
healing time.(61) 
 
Therefore, the primary purpose of the current investigation was to determine if chronic 
ingestion of either a WPC or its extensive hydrolysate (WPH), in combination with 
strenuous resistance exercise, resulted in any significant differences on measures of body 
composition, human performance and health in previously trained, healthy males.  A 
secondary purpose of the current investigation was to assess if different physiological 
adaptations to exercise occurred in response to whey proteins of varying PRO fraction 
concentration. 
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The following selected studies are specific to those variables that have direct 
implication(s) on either the proposed methods or hypothetical outcome(s) of the current 
investigation. 
 
EFFECT OF PROTEIN AND PROTEIN SOURCE ON PHYSIOLOGICAL RESPONSE AT REST AND IN 
RESPONSE TO EXERCISE 
Biolo G, Tipton KD, Klein S, Wolfe RR. An abundant supply of amino acids enhances 
the metabolic effect of exercise on muscle protein. Am J Physiol 1997 Jul;273(1 Pt 
1):E122-9.(62)  Six previously untrained males received intravenous infusion of 0.15 
g/kg/h x 3h of AA at rest and immediately after exercise.  AA uptake and effect on 
muscle was determined by isotopically labeled AA presence in arteriovenous blood 
samples and muscle biopsies.  Leg blood flow, in response to exercise and increased AA 
availability, increased by 64% above resting conditions, and amino acid transport 
increased by 30-100% above resting conditions for the four labeled AA under 
investigation.  MPS, but not MPB was significantly affected by combined exercise and 
AA availability; MPS increased by 291% in response to exercise plus AA, versus a 141% 
increase in MPS in response to AA alone under resting conditions.  IMPLICATION: This 
study was among the first to suggest that AA availability, immediately subsequent 
exercise, provides an increased anabolic response to exercise. 
 
Hayes A, Cribb PJ. Effect of whey protein isolate on strength, body composition and 
muscle hypertrophy during resistance training. Curr Opin Clin Nutr Metab Care 2008 
Jan;11(1):40-4.(58)  IMPLICATION: This review paper suggests PRO supplementation 
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supports at least three roles in augmenting the muscle hypertrophy response to heavy 
resistance exercise: 1) PRO ingestion close to training increases the anabolic response to 
exercise, 2) frequent PRO feeding appears to stimulate repeated increases in MPS and 
thus can promote higher net gains in muscle PRO accretion, and 3) PRO high in EAAs, 
and particularly leucine (ie., whey), may maintain or restore the acute anabolic response 
to PRO feeding that typically declines with age. 
 
Moore DR, Tang JE, Burd NA, Rerecich T, Tarnopolsky MA, Phillips SM. Differential 
stimulation of myofibrillar and sarcoplasmic protein synthesis with protein ingestion at 
rest and after resistance exercise. J Physiol 2009 Feb 15;587(Pt 4):897-904.(7)  Healthy 
but untrained male volunteers were studied, using muscle biopsies and primed constant 
infusion, to assess plasma AA concentrations, and myofibrillar and sarcoplasmic protein 
synthesis under fasting conditions and for five hours subsequent heavy unilateral 
resistance training; the non-exercised leg served as the rested state control.  Immediately 
post-exercise, subjects ingested 25 g WPI.  Both myofibrillar and sarcoplasmic protein 
synthesis were significantly (p<0.01) elevated in response to WPI feeding at "rest" and 
immediate post-exercise.  Myofibrillar protein synthesis increased in the trained leg 
compared to the untrained control at 1 (~100%), 3 (~216%) and peaked at 5 (~229%) 
hours post-exercise WPI ingestion.  Compared to a 103% rise in myofibrillar protein 
synthesis at five hours post-WPI alone (i.e., in the rested control leg), WPI+exercise  
raised protein synthesis 204% (p<0.01) by the same time point.  At three hours post-
exercise, it was observed that WPI alone or in combination with exercise significantly 
increased both myofibrillar and sarcoplasmic protein synthesis.  Exercise, however, was 
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shown to have no significant effect on sarcoplasmic rates of protein synthesis at any time 
point. IMPLICATION: These findings suggest that, 1) exercise only affects myofibrillar 
protein synthesis and that AA availability is required to stimulate sarcoplasmic protein 
synthesis, 2) that AA availability significantly increases the exercise-induced affect on 
myofibrillar protein synthesis, 3) PRO alone significantly triggers myofibrillar protein 
synthesis by three hours postprandial, and 4) combined exercise and PRO significantly 
increases protein synthesis for up to five hours post-exercise in previously untrained 
males.  Whether these effects are unique for WPI and WP, possibly because of their high 
concentration of BCAA and leucine, is yet to be determined.  However, these findings do 
support the hypotheses of regular protein feeding at 2-3-hour intervals to continually 
support MPS, and does suggest that WP may elicit a more anabolic response than other 
protein sources when combined with exercise. 
 
Hulmi JJ, Tannerstedt J, Selanne H, Kainulainen H, Kovanen V, Mero AA. Resistance 
exercise with whey protein ingestion affects mTOR signaling pathway and myostatin in 
men. J Appl Physiol 2009 May;106(5):1720-9.(16)  Previously untrained, college-aged 
male subjects were baseline tested for body composition by five-site skinfold and vastus 
lateralis muscle thickness, as assessed by ultrasound, prior to an acute bout of lower body 
resistance training and following 21 weeks of twice weekly exercise plus non-energetic 
placebo or 30 g/d WPI (15 g immediately pre- and post-exercise during both acute and 
chronic interventions).  Muscle biopsies were collected prior to, as well as one and 48 
hours post-exercise (acute intervention only), and 4-5 days subsequent the 21-day 
training intervention.  WPI resulted in significantly (p<0.05) elevated mTOR signaling at 
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1 and 48 hours post exercise, and sustained the mTOR response to exercise as observed 
after 48 hours acute and 21 weeks of repeated training.  Muscle thickness was also 
significantly (p=0.003) increased in the WPI group at both 10.5 and after 21 weeks of 
training.  Fiber size, as determined by immunohistochemical staining, revealed that both 
WPI and placebo significantly increased muscle cross-sectional area in both Type I and 
Type II fibers in response to the 21 weeks of twice weekly training, but no significant 
(p>0.05) differences were observed between groups (WPI = +41.55% and +51.34%; 
placebo = +40.78% and +50.55%).  No significant (p>0.05) within- or between-group 
changes were observed for %FAT, either.  IMPLICATION:  Total daily energy intake, 
including PRO intake, as averaged across the entire 21-week intervention, was shown to 
not be significantly different between the WPI and placebo groups (WPI = 1.5±0.3 g/kg 
b.w./d; placebo = 1.4±0.4 g/kg b.w./d; p=0.57).  Therefore, 1) it may not be surprising 
that little difference occurred between groups shown to be consuming statistically similar 
diets and engaged in the same exercise routine, 2) the significant increase, both at 
baseline and after 21 weeks, of acute  mTOR response from 15 g WPI consumed pre- and 
post-exercise, but no long-term differences between groups in muscle mass cross-
sectional area may be suggestive of a need for significantly higher chronic and/or daily 
doses of PRO, and 3) the non-significant changes in muscle cross-sectional area between 
the placebo and non-exercise control (sedentary, no WPI) group supports both the large 
variability likely to result from the use of previously untrained subjects or potentially the 
need for higher training volume and/or frequency. 
 
Hoffman JR, Ratamess NA, Tranchina CP, Rashti SL, Kang J, Faigenbaum AD. Effect of 
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protein-supplement timing on strength, power, and body-composition changes in 
resistance-trained men. Int J Sport Nutr Exerc Metab 2009 Apr;19(2):172-85.(63)  
Resistance trained men (intercollegiate athletes and competitive powerlifters) participated 
in a 4 d/wk x 10 wks, periodized resistance program, either with no supplemental 
intervention (control) or while consuming 84 g/d PRO (blend of hydrolyzed collagen 
protein isolate, WPI, CPI + 250 mg BCAA) in two divided doses: either immediately pre- 
and post-exercise (Pre/Post), or in the morning and evening regardless of training time 
(AM/PM).  Both PRO groups consumed two servings of PRO on non-training days.  All 
groups significantly (p<0.05) increased 1RM squat and both PRO groups significantly 
(p<0.05) increased 1RM bench press, however none of the changes were significantly 
(p>0.05) different between groups.  There were also no significant (p>0.05) differences 
within or between groups for BM, FM, %FAT or FFM as determined by DXA.  A 
significant (p<0.05) increase in daily protein intake was only observed in the AM/PM 
group, whereas relative PRO intake (g/kg b.w./d) increased, but non-significantly 
(p>0.05) in Pre/Post.  Relative intake of PRO as a percent of total macronutrient intake 
did, however, increase significantly in both AM/PM and Pre/Post.  No significant within- 
or between-group changes were observed for total energy (p=0.70), CHO (p=0.73) or 
FAT (p=0.73) intake during the investigation.  IMPLICATION:  1) Four days per week 
split-body periodized training was shown to significantly increase human performance 
measures in a highly trained population, and 2) no significant increase in daily PRO 
intake in Pre/Post coincided with an observed, albeit not significant reduction in total 
daily energy intake which may explain the significant increase observed in percent of 
total energy from PRO within this group (Pre/Post).  The latter observation, in light of 
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such high daily supplemental doses being added to the athletes' diets (84 g/d) may 
indicate prolonged satiety arising secondary to an augmented MPS response from 
combined resistance training and AA availability. 
 
Hoffman JR, Ratamess NA, Tranchina CP, Rashti SL, Kang J, Faigenbaum AD. Effect of 
a proprietary protein supplement on recovery indices following resistance exercise in 
strength/power athletes. Amino Acids 2009 Apr 4.(64)  Subjects were of the same 
population as the aforementioned Hoffman et al. study. (63)  Subjects consumed either 42 
g PRO (a PRO blend, as previously described) or an equal amount of maltodextrin 
(placebo) 10 minutes prior to and 15 minutes following an acute heavy resistance training 
bout.  The training on day one consisted of four sets of the back squat, deadlift and 
barbell lunge, utilizing an 80% 1RM load and allowing for 90 seconds of rest between 
sets.  Subjects returned 24 and 48 hours later to repeat pre- and post-exercise 
supplementation while performing only four sets of the back squat for maximal 
repetitions and following the same loading and rest interval lengths as on the day prior.  
No between-group differences (p>0.05) were observed for total training volume or 
hormonal response (e.g., testosterone, cortisol, creatine kinase, testosterone:cortisol) to 
the acute lower-body exercise session (Day 0).  A significant difference (p<0.05) was, 
however, observed between groups for total training volume at 24- and 48-hr repeated 
tests, with the PRO group performing more total reps (+30.4% and +40.9% more than 
placebo, respectively).  Additionally, whereas resting creatine kinase was significantly 
(p<0.05) elevated in both groups prior to the 24-hour back squat test, creatine kinase was 
not increased further in the PRO group prior to 48-hour testing but had increased 
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significantly (p<0.05) for the placebo group.  IMPLICATION: These results support an 
improved recovery response from pre- and post-exercise PRO, as opposed to CHO 
ingestion in strength/power athletes. 
 
Cribb PJ, Williams AD, Carey MF, Hayes A. The effect of whey isolate and resistance 
training on strength, body composition, and plasma glutamine. Int J Sport Nutr Exerc 
Metab 2006 Oct;16(5):494-509.(19)  Previously trained male subjects consumed, in 
double-blind manner, equal loads of PRO as either hydrolyzed whey protein isolate 
(WPH) or casein (CPH) in combination with 10 weeks supervised resistance training.  
WPH was determined to be significantly more effective than CPH at increasing 1RM 
strength (p<0.05) for the barbell bench press, parallel squat and lat pull-down, and at 
increasing FFM (+5.0±0.3 kg versus +0.8±0.4 kg; p<0.01) and reducing FM (-1.5±0.5 kg 
versus +0.2±0.3 kg; p<0.05) as assessed by DXA.  When strength was compared relative 
to BM, WPH was still significantly (p<0.05) more effective than CPH.  IMPLICATION: 
This study supports the hypothesis that WPH appears to improve physiological response 
to chronic resistance exercise in previously trained male subjects. 
 
Tang JE, Moore DR, Kujbida GW, Tarnopolsky MA, Phillips SM. Ingestion of whey 
hydrolysate, casein, or soy protein isolate: effects on mixed muscle protein synthesis at 
rest and following resistance exercise in young men. J Appl Physiol 2009,107(3):987-
92.(20)  The effects of consuming the equivalent of 10 g EAA as either WPH (21.4 g), 
micellar CP (21.9 g) or SPI (22.2 g) were assessed during rest and immediately following 
strenuous unilateral lower body resistance exercise in previously trained young (22.8±3.9 
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yrs) men.  Plasma insulin and blood amino acid concentrations, and mixed muscle 
fractional synthetic rate (FSR), a measure of muscle protein synthesis (MPS) were 
determined via blood draws and primed constant infusion, respectively.  Subjects' non-
exercise leg served as the control for assessing resting conditions.  Plasma insulin 
increased significantly (p<0.05) and comparably at 60 minutes post-supplementation for 
WPH and SPI, but not CP (p=0.43).  EAA and leucine concentrations increased (p<0.05) 
across all treatments by 30 minutes post-supplementation with WPH≈SPI>CP and 
WPH>SPI>CP, respectively.  Aminoacidemia at 30 minutes post was also significantly 
(p<0.05) greater for WPH than both SPI and CP (WPH>SPI>CP).  Similarly, at 60 
minutes post, EAA and leucine concentrations were significantly greater for WPH than 
SPI or CP (WPH>SPI>CP; p<0.05).  Leucine concentration AUC for the complete 180 
minutes post-supplementation period was 73% and 200% greater (p<0.05) than SPI and 
CAS, respectively.  At 180 minutes post-supplementation, MPS was significantly higher 
for WPH than CAS (93%; p<0.01) and tended to be higher than SPI (18%; p=0.067) 
under resting conditions.  In response to exercise, all groups significantly (p<0.05) 
increased MPS, but WPH resulted in significantly greater MPS than both SPI and CAS 
[31% (p<0.05) and 122% (p<0.01) greater, respectively].  Under both conditions, SPI 
resulted in significantly higher MPS than CAS [rest = 64% (p<0.01); exercise = 69% 
(p<0.01)].  IMPLICATION: 1) WPH>SPI>CP increases the absorption rate and 
availability of AA critical to support anabolism, 2) WPH>SPI>CP increases total leucine 
availability during the 3-hour period following combined heavy resistance exercise and 
PRO intake, 3) WPH>CP, and possibly greater than SPI, increases MPS in the absence of 
exercise, and 4) WPH>SPI>CP increases MPS response to exercise as assessed over the 
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3-hour period post-exercise.  Collectively, these findings support the hypothesis that fast 
absorbing PRO increases anabolism more than "slow" proteins both at rest and in 
response to exercise, and that PRO from WP supports a more anabolic environment than 
PRO from either native SPI or CP.  Also, significant MPS occurring three hours 
subsequent ingestion of WPH, under resting conditions, confirms similar findings 
presented earlier involving WP (7) and supports the dietary implementation of WP 
feedings occurring approximately every 2-3 hours to support a chronic anabolic 
environment. 
 
EFFECT OF PROTEIN QUALITY ON PHYSIOLOGICAL RESPONSE AT REST AND IN RESPONSE 
TO EXERCISE 
Tello PG, Camacho F, Jurado E, Paez MP, Guadix EM. Enzymatic hydrolysis of whey 
proteins. II. Molecular-weight range. Biotechnol Bioeng 1994 Aug 5;44(4):529-32.(65)  
This paper describes techniques used to hydrolyze PRO to achieve peptide hydrolysates 
of varying molecular weights.  A degree of hydrolysis (DH) of ≥20% was found to be 
required to achieve 65-95% of the hydrolysates as peptides of <1 kD in molecular weight.  
Similarly, this paper served as a review of the data on peptide chain length and absorption 
kinetics to date.  Specifically, that 1) free AA absorption appears to occur at a slower rate 
than for low molecular weight peptides because free AA share selective transporters, 2) 
di- and tri-peptides can be absorbed intact and hydrolyzed within the cell, and 3) to 
minimize potential allergenicity of ingested PRO and potentially increase AA kinetics, a 
PRO should contain a high biological value (e.g., WP) and be hydrolyzed such that the 
average molecular weight of its peptides is ~0.5 kD, but no more than 1 kD. 
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Calbet JA, Holst JJ. Gastric emptying, gastric secretion and enterogastrone response after 
administration of milk proteins or their peptide hydrolysates in humans. Eur J Nutr 2004 
Jun;43(3):127-39.(10)  In a cross-over design, six healthy adult males were randomly 
assigned to receive, via nasogastric tube, one of four double-blind PRO (9.3 g/L) 
solutions, equally matched for volume, nitrogen content, energy density, osmolality, pH 
and temperature: 80% WPC, hydrolysate of WPC80 (WPH), CP and CPH.  Before 
subject testing was conducted, it was determined that 94% of the peptides within WPH 
were an average of 3.7 residues in length, with only 6% of total nitrogen as free AA.  
CPH contained 93% of its peptides as chain lengths averaging 3.8 residues, with only 7% 
of its total nitrogen as free AA.  Gastric emptying and secretions were determined using a 
tritiated water technique that was reported to have good agreement with accepted 
methods (r=0.93 and r=0.86, respectively).  Rate of gastric emptying was shown to be 
similar for all PRO solutions.  Gastric secretions were elevated by approximately 50% in 
the first hour for WPH and CPH, compared to WPC and CP (p<0.05).  Hydrolysates 
maintained a significantly (p<0.05) higher gastric pH for up to 60 minutes post-feeding, 
despite all solutions being of equal pH when delivered nasogastrically.  Hydrolysis 
significantly affected the rate of appearance and magnitude of BCAA, EAA and total AA 
plasma concentrations for CP (CPH>CP; p<0.05) but not WP.  Peak AA concentrations 
occurred between 20-25 minutes for hydrolysates and 30-90 minutes for native PRO.  
Plasma glucose-dependent insulinotropic polipeptide (GIP) was significantly (p<0.05) 
and positively affected by hydrolysates.  IMPLICATION: Despite the requisite mode of 
delivery to assess gastric measures, it would appear that extensively hydrolyzed dairy 
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protein significantly increases absorption kinetics when compared to their native PRO 
source.  Also, hydrolysates may significantly affect insulin response more than their 
native PRO. 
 
Koopman R, Crombach N, Gijsen AP, Walrand S, Fauquant J, Kies AK, Lemosquet S, 
Saris WHM, Boirie Y, van Loon LJC. Ingestion of a protein hydrolysate is accompanied 
by an accelerated in vivo digestion and absorption rate when compared with its intact 
protein. Am J Clin Nutr 2009;90:106-15.(13)  Reported significantly (p<0.001) increased 
AA digestion and absorption, and a trend toward higher MPS (33±16%; p=0.10) and total 
net protein balance (+18.4%; p=0.08) when elderly male subjects consumed 35 g PRO as 
intrinsically L-[1-
13
C]phenylalanine labeled enzymatically hydrolyzed casein (CPH) 
versus intact casein (CP), under overnight fasted and rested conditions.  Subjects were 
chronically sedentary and this trial was of a double-blind, repeated measures, crossover 
design.  Total exogenous phenylalanine AUC, over the 6-hour period, was an average of 
27±6% (p<0.001) higher for CPH than CP, and total net protein balance over the 6-hour 
period tended (p=0.08) to be higher for CPH than CP.  Average total leucine flux (rate of 
appearance and rate of disappearance) was also significantly (p<0.05) higher for CPH 
than CP over the 6-hour period (7±1% and 8±2% higher, respectively).  Additionally, 
both peak and AUC plasma insulin concentrations were significantly greater for CPH 
than CP [~92% (p<0.01) and ~5x (p<0.05) higher, respectively], and peak AA 
concentrations for phenylalanine, tyrosine, leucine, valine and isoleucine were all 
significantly (p<0.05) greater for CPH than CP by ~25-50% each.  A nadir for each 
plasma AA was reached between the 4
th
 and 6
th
 hour of testing, such that each AA 
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became transiently, albeit significantly (p<0.05) lower for CPH than CAS.  
IMPLICATION: This study confirms the insulinotropic response, increased absorption 
rate and magnitude of plasma AA concentrations arising from hydrolysates versus the 
native PRO source.  The AA concentration nadir observed for hydrolysates, between four 
and six hours post ingestion would also seem to support previous non-exercise data that 
indicates a potential need for frequent PRO feeding intervals.  Lastly, hydrolysates of a 
PRO appear more effective at increasing muscle hypertrophy; however, work needs to be 
done with exercise and using trained subjects to validate. 
 
Power O, Hallihan A, Jakeman P. Human insulinotropic response to oral ingestion of 
native and hydrolysed whey protein. Amino Acids 2008 Aug 5.(11)  Sixteen healthy 
young men participated in a double-blind, repeated measures, cross-over trial to assess 
the effects of an acute dose of 45 g WP as either WPI or an extensively hydrolyzed 80% 
WPC (WPH).  Testing was conducted after an overnight fast and under resting 
conditions.  WPH was reported as a 30% DH and contained 93% of its peptides as ≤1 kD 
in molecular weight; by contrast, 83% of the peptides in the WPI were >5 kD.  Plasma 
insulin increased under both conditions but peaked between 30-50 minutes for WPI, 
whereas insulin continued to rise with WPH (+28% above WPI; p=0.018) and peaked 
between 50-90 minutes post-PRO load (p=0.20).  Area under the curve for plasma insulin 
concentration, over the 3-hour postprandial period, was also higher for WPH (+43%; 
p=0.21) but did not reach significance.  Likewise, there was no difference between 
groups for changes in plasma glucose.  A non-significant (p=0.15) trend toward faster 
gastric emptying was observed for WPH, however, both WPH and WPI had completely 
40 
 
emptied from the stomach by 120 minutes postprandial, which led the researchers to 
conclude WP yields an average gastric emptying rate of 1.5286 kcal/min.  BCAA rate of 
appearance increased steeply but there was no difference for BCAA rate of appearance 
between groups for up to 40 minutes postprandial.  Peak BCAA and total area under the 
curve was, however, 8% (p=0.176) and 15% (p=0.07) higher for WPI than WPH.  
Phenylalanine response revealed a 10% (p=0.003) higher peak concentration and 22% 
(p=0.23) greater area under the curve for WPH versus WPI.  Regression analysis revealed 
no correlation between BCAA or phenylalanine concentrations and insulin response.  
IMPLICATION: Physiological response to, and amino acid kinetics arising from WPH 
and WPI differ in healthy males under fasted, rested conditions.  Also, a significantly 
higher, and possibly total insulin response can likely be expected from WPH versus WPI, 
and complete clearance of 45 g "fast" WP occurs by approximately three hours 
postprandial (under prior fasting and rested conditions). 
 
Buckley JD, Thomson RL, Coates AM, Howe PR, Denichilo MO, Rowney MK. 
Supplementation with a whey protein hydrolysate enhances recovery of muscle force-
generating capacity following eccentric exercise. J Sci Med Sport 2008 Sep 1.(66)  Knee 
extensor peak isometric torque, perceived muscle soreness, and muscle damage (serum 
creatine kinase activity) and inflammation (plasma TNFα concentrations) were assessed 
after an overnight fast (baseline) and repeated 1, 2, 6 and 24 hours after performing 100 
maximal eccentric contractions on an isokinetic dynamometer set at an angular velocity 
of 40°/s and performed through an 80° range of motion.  Immediately after baseline 
testing, and again after the 6th and prior to the 24th hour follow-up tests, subjects – 
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healthy, sedentary college-age males – consumed one of three double-blind drinks: 25 g 
PRO from WPI or hydrolyzed WPI (WPH), or flavored water (placebo).  Thus, a total of 
75 g PRO was supplemented to the WPI and WPH subjects' 24-hour diets.  Peak 
isometric torque decreased across all groups immediately post-exercise (-23%) but 
returned to baseline levels by hour-6 in response to WPH.  However, peak isometric 
torque remained suppressed over the 24-hour period for both WPI and placebo (ANOVA 
treatment x time interaction; p=0.006).  No changes within or between groups occurred 
for muscle soreness, damage or inflammation.  IMPLICATION: WPH consumed post-
exercise overload may have significantly augmented the anabolic response of combined 
exercise and increased AA availability via increased maximal and total insulin response.  
These findings may indicate faster recovery from high-intensity, high-volume training, 
and therefore greater time under tension of muscle to stimulate increases in muscle 
hypertrophy. 
 
EFFECT OF PROTEIN DOSE ON PHYSIOLOGICAL RESPONSE AT REST AND IN RESPONSE TO 
EXERCISE 
Moore DR, Robinson MJ, Fry JL, Tang JE, Glover EI, Wilkinson SB, Prior T, 
Tarnopolsky MA, Phillips SM. Ingested protein dose response of muscle and albumin 
protein synthesis after resistance exercise in young men. Am J Clin Nutr 2009 
Jan;89(1):161-8.(26)  Young adult males with a minimum of four months prior weight 
training experience performed an acute bout of heavy leg training under overnight fasted 
conditions on five occasions, separated by 1-week wash-out intervals.  Immediately 
following each exercise bout, subjects were randomly assigned to consume varying doses 
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of egg albumin PRO – 0, 5, 10, 20 or 40 g.  Primed constant infusion of [1-13C]leucine 
and muscle biopsies were used to assess whole-body leucine oxidation, MPS, albumin 
protein synthesis (APS) and blood amino acid concentrations over a 4-hour postprandial 
period.  MPS has been shown to increase in response to PRO plus exercise, whereas APS 
does not respond to exercise but is a hepatic-derived plasma protein that is stimulated by 
increased AA availability and may function to store excess AAs.  MPS and APS 
increased in a dose-dependent manner up to the 20 g dose, with a higher absolute but not 
statistically significant mean response for the 40 g dose.  Specifically, MPS increased by 
approximately 37 and 56% for the 5 and 10 g doses, respectively, and approximately 93% 
for both the 20 and 40 g doses.  APS followed the same curvilinear pattern: 0 g<5 g<10 
g<20 g≈40 g.  Only the 40 g dose significantly (p<0.01) increased EAA, BCAA and 
leucine concentrations at all time points, and these values were significantly (p<0.01) 
different from all other PRO doses.  Insulin concentration was not significantly different 
for time x treatment, however, total insulin area under the curve was significantly 
(p<0.01) greater for the 40 g than for the 5 and 10 g doses, and tended (p=0.09) to be 
higher than what was observed in response to the 20 g dose.  IMPLICATION: The 
researchers concluded that 20 g PRO is the uppermost, optimal dose for maximizing 
protein synthesis, and that above this amount AA will be lost to irreversible oxidation.  
Similarly, the researchers suggest that more than 5-6 servings of 20 g PRO, per serving, 
would result in oxidative loss and could lead to downregulation of the protein synthetic 
response.  However, leucine oxidation under both the 20 and 40 g dosing was 
significantly higher than for 0, 5 and 10 g, but there was no significant difference 
between the oxidation rates observed between 20 and 40 g.  Similarly, a 50% increase in 
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PRO exists between doses of 20 and 40 g, and thus it is possible that the optimal dose per 
serving may lie between these two values.  Also, as has been shown rather convincingly 
out of the same lab, PRO source has a significant effect on MPS, both at rest and in 
response to exercise.(20)  Thus, it remains to be seen if the same absolute dose responses 
occurs following the ingestion of other PRO sources and/or different training protocols. 
 
Claessens M, Saris WH, van Baak MA. Glucagon and insulin responses after ingestion of 
different amounts of intact and hydrolysed proteins. Br J Nutr 2008 Jul;100(1):61-9.(29)   
In sedentary, but non-obese adult males, plasma insulin and glucagon response to 0.3, 0.4 
and 0.6 g/kg b.w PRO was evaluated. The effects of PRO from WPI, SPI, and their 
respective hydrolysates (WPH and SPH, respectively) was assessed under resting 
conditions and after a 10-hour fast by single-blind, crossover, repeated measures design.  
Blood was sampled at baseline and 15, 30, 60, 90 and 120 minutes postprandial.  WPH 
contained 82% of its fractions as low molecular weight peptides (≤1 kD) and SPH was 
reported to contain 77% of its fractions as ≤1 kD.  Increasing SP dose, whether SPI or 
SPH, increased insulin total area under the curve response in a dose-dependent manner 
(p=0.001).  Significant within-group differences for insulin response also existed for both 
SPI and SPH: 0.6>0.4≈0.3 g/kg b.w. dose.  Total area under the curve for both insulin 
and glucagon were significantly greater for SPI than SPH (p=0.018 and p=0.001, 
respectively), and in both cases SPI resulted in a faster increase in both hormones.  
Significant differences (p<0.05) were also present for glucagon response for both SPI and 
SPH, between 0.3 and 0.4 g/kg b.w. doses, however, only SPH realized a significant 
difference (p<0.05) between 0.4 and 0.6 g/kg b.w. doses.  WPI and WPH also resulted in 
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significant dose-dependent increases in insulin response area under the curve (p<0.001); 
however, within-group differences were not observed for WPH but were significantly 
different for WPI (0.6≈0.4>0.3 g/kg b.w.; p≤0.002).  A significant (p=0.002) interaction 
effect was observed for glucagon (WPH>WPI; p≤0.004), such that plasma glucagon rose 
and decreased faster with increasing doses of WPH.  Additionally, SPI and SPH provided 
similar and non-significant effects (p>0.05)  on plasma glucose, whereas total area under 
the curve for glucose decreased significantly (p=0.001) with increasing WP loads.  
IMPLICATION: The primary finding of this study is that, 1) WPH and WPI appear to 
differentially affect plasma insulin and glucagon response, and 2) the effects are 
generally dose-dependent up to 0.6 g/kg b.w. PRO dose. 
 
EFFECT OF AGE AND TRAINING EXPERIENCE ON PHYSIOLOGICAL RESPONSE TO COMBINED 
PROTEIN INTAKE AND EXERCISE 
Kumar V, Selby A, Rankin D, Patel R, Atherton P, Hildebrandt W, Williams J, Smith K, 
Seynnes O, Hiscock N, Rennie MJ. Age-related differences in the dose-response 
relationship of muscle protein synthesis to resistance exercise in young and old men. J 
Physiol 2009 Jan 15;587(Pt 1):211-7.(6)  Twenty-five young (24±6 yrs) and older (70±5 
yrs) males were studied to assess MPS and anabolic signaling in response to varying 
resistance exercise intensities (20-90% 1RM).  Total training volume was maintained 
across all exercise intensities.  A significant (p<0.05) difference was observed for MPS 
between young and older men, both in response to each exercise intensity and at 1-2 
hours post-exercise; most notably in response to training intensities between 60-90% 
1RM [MPS was 30±6% higher (p<0.04) in younger males].  IMPLICATION: It was 
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concluded that MPS increases in a dose-dependent manner with exercise intensity up to 
60% 1RM, and that older men appear to have a blunted anabolic response to resistance 
training across all intensities when compared to younger males. 
 
Drummond MJ, Dreyer HC, Pennings B, Fry CS, Dhanani S, Dillon EL, Sheffield-Moore 
M, Volpi E, Rasmussen BB. Skeletal muscle protein anabolic response to resistance 
exercise and essential amino acids is delayed with aging. J Appl Physiol 2008 
May;104(5):1452-61.(67)  Young and older (29.7±1.7 and 70.0±2.1 yrs, respectively), 
healthy males were studied to assess MPS, anabolic signaling, and plasma AA, hormone 
and glucose:lactate concentrations in response to 8 sets x 10 reps/set of 70% 1RM knee 
extension training and immediate post-exercise ingestion of 20 g EAA.  MPS was 
significantly elevated in the younger males by 1-3 hours post, and this MPS response was 
significantly greater than that of the older males at the same time point (p<0.05).  A 
significant within-group increase in MPS for the older males was only observed between 
3-6 hours post, however there was no significant difference between younger and older 
males during that same period.  Significant within- and between-group differences were 
also observed for AMP-activated protein kinase-alpha (AMPKα) phosphorylation, a 
negative regular of protein synthesis.  Specifically, AMPKα was significantly elevated in 
older males at 1 and 3 hours post (p<0.05), which was significantly higher than AMPKα 
phosphorylation observed in the younger males (p<0.05). IMPLICATION: Older subjects 
appear to have a delayed MPS response to combined resistance training and AA 
availability, and therefore subject recruitment for the purposes of the current investigation 
was drawn from a younger population. 
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EFFECT OF WHEY PROTEIN AND IT'S PEPTIDES ON HEALTH AND DISEASE 
Micke P, Beeh KM, Buhl R. Effects of long-term supplementation with whey proteins on 
plasma glutathione levels of HIV-infected patients. Eur J Nutr 2002 Feb;41(1):12-8.(43)  
Thirty HIV-infected patients consumed 45 g WP as either double-blinded WPC or WPH, 
twice per day x 2 weeks.  Plasma total glutathione increased by 44% (p=0.004) and 
24.5% (p=0.43) for WPH and WPC, respectively.  All patients were switched to WPH 
and continued consuming 90 g supplemental PRO, per day, for an additional six months.  
Plasma glutathione remained significantly elevated (+26.7%; p=0.033), while there was 
no significant change in BM, T-cell counts or other clinical measures of interest.  
IMPLICATION: Clinical application notwithstanding, WPH appears to be more effective 
than WPC at increasing circulating concentrations of the body's primary antioxidant, 
glutathione.  This may have an effect on training recovery in healthy populations engaged 
in strenuous weight training. 
 
Sattler FR, Rajicic N, Mulligan K, Yarasheski KE, Koletar SL, Zolopa A, Alston Smith 
B, Zackin R, Bistrian B. Evaluation of high-protein supplementation in weight-stable 
HIV-positive subjects with a history of weight loss: a randomized, double-blind, 
multicenter trial. Am J Clin Nutr 2008 Nov;88(5):1313-21.(44)  Fifty-nine weight stable 
HIV-infected patients with prior weight loss of greater than 3% were randomly assigned 
to receive one of two double-blinded 280 kcal/serv supplements, twice per day x 12 
weeks – 40 g WPI or isocalorically matched CHO placebo.  No changes in BM, FFM or 
self-selected food intake occurred, however fasting triglycerides decreased in response to 
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WPI (-16 mg/dL; p=0.03) and increased with CHO (+39 mg/dL; p=0.025).  CD4 
lymphocytes, which decline as a result of HIV and are indicative of immune function, 
increased in response to WPI (+31 cells/mm
3
; p=0.03) and decreased with CHO (-5 
cells/mm
3
; p=0.03).  IMPLICATION: Aside from CHO ingestion increasing 
cardiovascular risk factors in HIV-positive patients, this study indicates that WP may 
improve exercise recovery and aid in preventing over-reaching and over-training due to 
an increase in training volume combined with high-intensity exercise. 
 
Marshall K. Therapeutic applications of whey protein. Altern Med Rev 2004 
Jun;9(2):136-56.(68)  This review article describes the whey protein fractions and 
biologically active peptides that had, at the time, been found to yield immune-enhancing 
effects.  Brief study summaries provide evidence that bioactive peptides, or other 
fractional elements deriving from WP may increase antioxidant and ACE-inhibiting 
effects, and possess antihypertensive, hypolipidemic, antiviral, antibacterial and chelating 
actions.  Clinical trials involving the successful use of WP in the treatment of 
osteoporosis, HIV, hepatitis B, cardiovascular disease and cancer are also discussed.  
IMPLICATION: Many of the immune-enhancing properties present in dairy, derive from 
WP.  WPC maintains the native structure of the peptides and thus may provide an 
improved effect on immune response and recovery, independent of an increased insulin 
or MPS response that may occur in response to WPH.  Similarly, WPC of higher 
lactoferrin concentration – a widely recognized immune-enhancing WP fraction – may 
augment exercise recovery. 
 
48 
 
Adibi SA. Regulation of expression of the intestinal oligopeptide transporter (Pept-1) in 
health and disease. Am J Physiol Gastrointest Liver Physiol2003 Nov;285(5):G779-
88.(40)  This paper provides a thorough review of the independent variables that affect 
Pept-1 transporter expression and action in the context of human health and disease.  Of 
the independent variables that affect Pept-1 transporter expression: high PRO intake has 
been shown to increase Pept-1 gene expression 1.5-2x compared to low PRO, in as little 
as three days and for up to two weeks; insulin rapidly stimulates Pept-1; triiodothyronine 
(T3) hormone may directly or indirectly downregulate peptide uptake by Pept-1; diurnal 
rhythm; developmental age; fasting – both acute or prolonged – increases Pept-1 
expression; diabetes increases Pept-1 expression, independent of insulin; short-bowel 
syndrome, Crohn's disease and ulcerative colitis have been shown to increase Pept-1 
expression within the colon (Pept-1 is predominant in the small intestine); antibiotics 
downregulate Pept-1 expression; and α2-adrenergic agonists may upregulate Pept-1.  It 
has also been identified that l-valine ester containing di- and tri-peptides possess very 
high bioavailability and are currently being exploited for use in drug development and 
transport.  IMPLICATION: Inclusion/exclusion criteria included disease states shown to 
affect Pept-1 transporters; known α2-adrenergic agonists, such as yohimbine, were not 
allowed for use by participants within this study; and subjects were excused from the 
study in the event they required the use of antibiotics. 
 
Morifuji M, Koga J, Kawanaka K, Higuchi M. Branched-chain amino acid-containing 
dipeptides, identified from whey protein hydrolysates, stimulate glucose uptake rate in L6 
myotubes and isolated skeletal muscles. J Nutr Sci Vitaminol (Tokyo) 2009 Feb;55(1):81-
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6.(30)  This study presented in vitro and in situ analyses of the effects of BCAA-
containing dipeptides, derived from enzymatically hydrolyzed WP (WPH), on rat skeletal 
muscle glucose uptake and storage.  Seven BCAA dipeptides were detected, with 
Isoleucine-Leucine and Valine-Leucine being the most prevalent (3.69 and 3.62 mg/g, 
respectively); almost all of the dipeptides deriving from β-lactoglobulin.  All dipeptides 
resulted in significant (p<0.05) uptake of glucose into skeletal muscle cells by a 
minimum of 33% (Isoleucine-Leucine dipeptide) and up to 55% (Isoleucine-Isoleucine).  
By comparison, insulin acted as a positive control and was found to yield 75% greater 
uptake of glucose in myotubes.  Only Isoleucine-Leucine was further assessed for its 
affects on glycogen concentration and was found to significantly (p<0.05) increase 
glycogen concentration by 18%.  IMPLICATION: It is possible that the increased insulin 
response observed from the consumption of fast-absorbing WP (BCAA concentration for 
WPI>WPC) is being affected by a high concentration of these insulinotropic BCAA-
containing dipeptides.  Theoretically, enzymatic hydrolysis of a high-β-lactoglobulin 
containing WP could be engineered to deliver an abundance of these dipeptides in high 
concentration and thereby promote a more dramatic insulin response. 
 
Mulder AM, Connellan PA, Oliver CJ, Morris CA, Stevenson LM. Bovine lactoferrin 
supplementation supports immune and antioxidant status in healthy human males. Nutr 
Res 2008;28(9):583-9.(48)  Healthy, male adults were administered a placebo, and 100 
mg and 200 mg of whey-derived lactoferrin for seven days (each arm), in a repeated 
measures design.  Blood lymphocytes, T-cell activation, natural killer cell cytotoxicity, 
and serum cytokine levels (e.g., tumor necrosis factor-alpha) and antioxidant status were 
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measured prior to and after each intervention period.  No significant effect (p>0.05) was 
observed in response to either the placebo or 100 mg/d interventions for any of the blood 
measures analyzed.  However, T-cell activation (total, helper and cytotoxic) was found to 
be significantly elevated (p<0.001; compared to baseline and post-placebo intervention) 
after one and seven days of repeated use of the 200 mg/d lactoferrin dose.  Hydrophilic 
antioxidant capacity also was found to be significantly different from baseline, though 
not significantly different (p>0.05) from post-placebo measures.  IMPLICATION: The 
results of this study may support the supplemental use of 200 mg/d lactoferrin, or a whey 
protein manufactured to contain comparably high concentrations of lactoferrin, to 
improve immune function and possibly aid exercise recovery (or least decrease the 
likelihood of over-reaching/over-training onset).  However, complicating this conclusion 
is that the three treatment arms were not provided in random, cross-over design and nor 
was a washout period included between interventions.  Instead, placebo and then 100 
mg/d always preceded the 200 mg/d treatment. 
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METHODS 
 
STUDY DESIGN 
This study involved a minimal nutrition (ad libitum) intervention, double-blind, placebo-
controlled, randomized, repeated measures design.  The study design was selected to 
simulate “real world” application of consuming 30 g of whey protein (WP), 2x/d x 8 wks, 
in combination with 4 d/wk heavy resistance training in healthy, college-aged, resistance-
trained males.  Subjects were randomly assigned into 1 of 4 treatment groups: exercise + 
dextrose placebo control (PLA), exercise + whey protein concentrate 80% (WPC80), 
exercise + high lactoferrin-containing whey protein concentrate 80% (WPC80+), or 
exercise + extensively hydrolyzed whey protein concentrate 80% (WPH).  All subjects 
consumed two supplements per day; immediately pre- and post-exercise on training days, 
and twice daily between meals on non-training days.  Body composition testing occurred 
on day 1 of week 0 (PRE) and week 9 (POST), following a 12-hour fast (water only) and 
a minimum of 48 hours without participating in strenuous exercise.  Nine blood draws 
occurred: immediately following body composition testing in PRE and POST; 24 hours 
after the first and final lower body workout in weeks 1 and 8, and following a 4-hour fast; 
immediately following POST strength (1RM) and anaerobic endurance testing (80RM); 
and, immediately prior to and following 24- and 48-hour repeated anaerobic endurance 
testing (80RM24 and 80RM48, respectively) in POST.  Upper- and lower-body 1RM and 
80RM testing was initiated 48 hours after body composition testing in PRE and POST, 
with upper- and lower-body 1RM tests preceding upper- and lower-body 80RM testing.  
Twenty-four and 48-hour repeated 80RM testing only occurred during POST.  Three-day 
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nutritional diaries were recorded before PRE (baseline), and again during weeks 1, 4-5 
and 8 of the intervention.  Subjects also recorded nutritional intake for the 24 hours 
preceding strength and anaerobic endurance tests.  For testing and training day sequence 
of events, refer to Figure 1 in Appendix B. 
 
SUBJECTS 
Sixty-eight (N≥68) healthy, resistance-trained (≥ 3 months uninterrupted,  ≥ 3 d/wk 
resistance training) men, 18-35 years of age (21.40±0.36), volunteered to participate in 
the study.  Each participant was assessed for inclusion into, or exclusion from the study 
via responses provided during verbal interviews as well as written (and signed) health 
history and related documents.  One subject from WPC80+ withdrew because of a 
shoulder injury (received outside of the study), two subjects (1 WPH and 1 WPC80) were 
removed for non-compliance and missed workouts, two subjects from WPH were 
removed because of viral infections requiring the use of antibiotics, four subjects (1 PLA, 
2 WPH, and 1 WPC80) withdrew because of the training being of too high an intensity, 
and two subjects (1 PLA and 1 WPH) withdrew because of headaches brought about 
during lower-body training.  Additionally, data from one subject within WPC80 was 
removed from final analysis on the basis of being an extreme (>3 SD) outlier for PRE 
body mass (BM), percent body fat (%FAT), one repetition maximum on the bench press 
(1RM BP), and height.  Therefore, 57 subjects completed the study, and data from 56 
subjects were used for analyses [refer to Table 1 in Appendix A].  This study was 
approved by the University of Oklahoma Health Sciences Center Institutional Review 
Board for Human Subjects, and written informed consent was obtained from each 
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participant prior to testing. 
 
INCLUSION AND EXCLUSION CRITERIA 
Inclusion into the current study was in accordance with previous research methods used 
within the University of Oklahoma, Department of Health and Exercise Science Human 
Performance Laboratory, and entailed that each subject meet the following criteria: 
 College-aged male between the ages of 18-35 
 ≥ 3 months of continuous resistance training (≥ 3 d/wk) experience, for the period 
immediately prior to the start of the investigation 
 Apparently healthy and free from disease as determined by a health history 
questionnaire 
 Provided written consent and agreed to all of the conditions of the protocol 
 Had not used dietary supplements that may confound the results of the study (e.g., 
creatine, stimulants, thermogenics, etc.) within 14 days of PRE testing, and agreed 
to not engage in supplementation of such products or additional protein 
supplementation during the course of the study 
 Agreed to not engage in supplemental resistance or aerobic exercise during the 
course of the study 
 
Participants were excluded from participation in the study if they reported or exhibited 
any of the following: 
 Participated in another clinical trial or had received an investigational product 
within 30 days prior to enrollment 
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 Lost or gained >10 lbs of bodyweight during the previous six months, and had 
maintained the change in weight 
 Did not eat meals at regular intervals 
 History of drug or alcohol abuse within two years prior to enrollment 
 Regular use of tobacco products (i.e., cigarettes, dip, snuff, chew, cigars, etc.) 
 Significant history, or existing presence of a treated or untreated bleeding 
disorder, diabetes mellitus, high blood pressure (systolic > 140 and/or diastolic > 
90 mmHg), thyroid disease, tachyarrhythmia, heart disease, kidney disease or 
liver disease 
 Having had an abnormal electrocardiogram 
 Existing sleep disorder and/or being treated for (or a known history of) clinical 
depression, eating disorder(s) or any other psychiatric condition(s) that may 
confound the results of the study 
 Known allergy or sensitivity to any ingredient contained within either of the three 
test formulas or placebo (inclusive of persons with phenylketonuresis, lactose 
intolerance or dairy food allergies) 
 Any findings on the health status questionnaire that represented a clinically 
significant deviation from normal/acceptable 
 A medical condition or use of any medication that may place the subject at risk or 
confound the results of the study 
 Use of any androgenic anabolic steroids, “pro-hormones”, or related precursors or 
salts within one year prior to enrollment 
 Missed > 1 training session per week or was not complying with the study 
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guidelines or controls (e.g., consuming additional supplements, engaging in 
supplemental exercise, etc.) 
 Identified as a moderate-to-high risk individual as described by the American College 
of Sports Medicine (69) (i.e., possessing > 1 of the following): 
 Father or brother, or mother or sister that had a sudden death before 55 or 65 
years of age, respectively 
 Current cigarette smoker or quit smoking < 6 months prior to enrollment 
 On hypertensive medication or had a confirmed systolic or diastolic blood 
pressure ≥ 140 or 90 mmHg, respectively 
 On lipid lowering medication or had a total cholesterol level ≥ 200 mg/dL 
 A confirmed fasting blood glucose of ≥ 100 mg/dL 
 Clinically obese (> 32% body fat) 
 Sedentary 
 
NUTRITIONAL ANALYSIS 
All participants were instructed to maintain pre-study, ad libitum dietary habits and asked 
to provide three-day nutrition logs for the week prior to baseline (PRE) testing, as well as 
for weeks 1, 4-5, and 8 of the intervention, for a total of four weeks of nutrition logs.  
Each log included two non-consecutive weekdays and one weekend day, and was used to 
represent subjects’ average weekly diets.  Logs were analyzed for total energy (CALS; 
kcals/d and kcals/kg/d), macronutrient [FAT (g/d, g/kg/d, % of kcals/d, and Unsaturated, 
Saturated and Trans-), CHO (g/d, g/kg/d, % of kcals/d, and Sugar and Fiber), and PRO 
(g/d, g/kg/d, and % kcals/d)], essential vitamins and minerals, caffeine and alcohol intake 
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per day, using Food Processor Version 8.6.0 (ESHA Research, Salem, Oregon).  Results 
obtained for weeks 1, 4-5, and 8 were combined to provide an average daily value across 
each nutritional variable for the 8-week intervention.  Subjects also recorded nutritional 
intake for the 24 hours preceding baseline (PRE) 1RM and 80RM testing.  For 1RMPOST, 
80RMPOST and repeated 80RM testing, subjects were provided a copy of their baseline 
24-hour nutrition log and required to replicate (as closely as possible) the same 
nutritional intake prior to and during all 1RM, 80RM and repeated 80RM testing days 
(with the addition of twice daily supplementation occurring during POST testing). 
 
EXERCISE PROTOCOL 
The resistance training intervention involved an 8-week, split-body, linear periodized 
program as used previously by Kerksick et al.(70)  Subjects participated in supervised 
upper- and lower-body heavy resistance training 2x/wk, for a total of four workouts per 
week x 8 wks.  Training and recovery days followed a 2-on/1-off/2-on/2-off schedule 
(e.g., Monday-UPPER, Tuesday-LOWER, Wednesday-OFF, Thursday-Upper, Friday-
Lower, Saturday-OFF, Sunday-OFF, repeat).  A 5-minute moderate intensity, continuous 
motor recruitment warm-up (e.g., stationary cycling or treadmill jogging) preceded each 
workout session.  Resistance exercises targeted all major muscle groups and consisted 
primarily of multi-joint movements.  After the 5-minute warm-up, bench press and hack 
squat were always performed first on upper- and lower-body training days, respectively.  
Exercise order for the remaining exercises was not controlled.  Subjects completed three 
sets per exercise, allowing one-minute rest between sets and two-minute rest periods 
between exercises, using a 10-12RM and 5-8RM load for weeks 1-4 and 5-8, 
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respectively.  Refer to Figure 2 in Appendix B, for the resistance training program used 
during the 8-week intervention.  Subjects were instructed to complete each set to 
volitional muscle failure, adjusting the load lifted accordingly to ensure all sets were 
completed within the requisite repetition range.  All subjects were provided a stopwatch 
to ensure accuracy of rest period duration and to track total workout duration.  All 
subjects recorded loads used and successfully completed repetitions per set, and total 
training time and sets on individually marked training logs.  Upper- and lower-body, as 
well as total training volume were calculated for each subject, week and total over the 
entire eight weeks as follows: Absolute Volume (Kg) = (load x reps) x sets; Relative 
Volume (Kg/min) = Absolute Volume / time.  Subject training logs were assessed weekly, 
and prescriptive loads provided for the subsequent week's workouts.  All participant 
workouts were supervised by an ACSM or National Strength and Conditioning 
Association certified strength and conditioning specialist or trainer. 
 
DIETARY SUPPLEMENT INTERVENTION 
Beginning 48 hours after completion of 1RMPRE and 80RMPRE testing, participants began 
consuming 1 of 4 double-blind treatments – PLA, WPH, WPC80+ or WPC80 – twice 
daily for 62 consecutive days (i.e. each day of the 8-week training intervention and POST 
testing period).  All treatments were formulated to contain similar amounts of total 
energy and lipid, and all treatments were double-blinded for appearance, taste, texture 
and packaging.  Supplements were consumed immediately pre- and post-exercise on 
training days, and twice daily between regularly scheduled meals on non-training days.  
On training days, subjects were provided their supplements, pulled from individually and 
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randomly assigned cases of their randomly assigned within-group product allotment.  
Prior to non-training day periods, subjects were allocated enough product for full 
compliance until the next scheduled training day.  Subjects were instructed to consume 
the supplement on an empty stomach (i.e., no closers than 90 minutes after a prior meal) 
and not to consume food or other energy-containing items within 30 minutes after 
supplement consumption.  To mix the supplement, subjects were instructed to fill a 
shaker cup with 6-8 fl ozs of water, empty the contents of their individually labeled 
packet into the water, add ~2 fl ozs of water to the empty packet, mix and pour the 
remaining contents of the packet into the shaker cup, shake contents of the cup 
vigorously for ~1-2 minutes, let the solution settle for ~2-3 minutes, consume within 5 
minutes, add an additional 2-4 fl ozs of water to the cup, shake vigorously, and consume 
the remaining dilute. 
 
The placebo (PLA) was formulated with 30 g of dextrose anhydrous per serving, as well 
as minor amounts of reduced-fat dairy creamer and xanthan gum to both equilibrate the 
lipid content across all treatments and to double-blind the treatments for viscosity and 
appearance.  The WPC80 group consumed 30 g of PRO from an 80% whey protein 
concentrate (Carbelac
®
, Carbery, Cork, Ireland), whereas subjects in the WPC80+ group 
consumed 30 g of PRO from a high-lactoferrin containing 80% whey protein concentrate 
(Progenex Dairy Bioactives, Inc, Costa Mesa, CA).  Subjects in WPH consumed 30 g of 
PRO from an extensively hydrolyzed (32% degree of hydrolysis) 80% whey protein 
concentrate (Optipep™, Carbery, Cork, Ireland), designed to provide greater than 80% of 
its protein fractions as <1 kD in molecular weight (see Figure 3, in Appendix B, for the 
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complete molecular weight distributions/profiles of each of the whey proteins used in this 
study).  All treatments were formulated with sucralose, orange flavoring and citric acid, 
whereas the WPH treatment additionally required the use of a mint-based masking agent 
to reduce bitterness (see Figure 4, in Appendix B, for complete nutritional profiles across 
all treatments).  All groups consumed two supplements per day, for a total of 60 g/d of 
active material or placebo.  Final formulation, packaging and double-blinding was 
conducted at and by a cGMP compliant manufacturing facility (CSB Nutrition, Lindon, 
UT), and un-blinding was provided by the manufacturer's representative agent upon 
request by the study coordinator after all statistical analysis had been completed. 
 
UPPER- AND LOWER-BODY STRENGTH 
One-repetition maximum (1RM) upper- and lower-body strength was determined using 
the barbell flat bench press (1RM BP) and incline plate-loaded hack squat machine (1RM 
HS), respectively.  Subjects performed two warm-up sets prior to 1RM attempts.  The 
first warm-up allowed subjects to perform 10 repetitions of an estimated 50% 1RM, 
whereas the second warm-up set utilized an estimated 80% 1RM load for 2-3 repetitions.  
Warm-up sets and all subsequent 1RM attempts were separated by 3-minute recovery 
periods, (71) and no more than five 1RM attempts were allowed for either the BP or HS.  
Subjects performed 1RM BP attempts prior to 1RM HS testing, and only correctly 
performed repetitions were accepted for data collection purposes.  During all BP and HS 
attempts, a spotter (or spotters) assisted in un-racking the weight and to ensure subject 
safety. 
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UPPER- AND LOWER-BODY ANAEROBIC ENDURANCE 
Upper- and lower-body anaerobic endurance (80RM) was determined using the barbell 
flat bench press (80RM BP) and incline plate-loaded hack squat machine (80RM HS), 
respectively.  Five to seven minutes recovery was provided between 1RM testing and 
initiation of 80RM tests.(72)  Subjects performed one maximal effort set to volitional 
exhaustion (for total number of repetitions completed), of both the BP and HS, using a 
80% 1RM load of the respective exercise.  Subjects performed 80RM BP testing prior to 
80RM HS.  Three to five minutes recovery was allowed between 80RM BP and 80RM 
HS attempts.  Repetitions that were not performed using proper form/acceptable range of 
motion were deducted from the total repetitions completed, and subjects were not 
allowed to pause for greater than two seconds after the completion of each repetition 
while performing 80RM attempts. During POST testing, subjects consumed a supplement 
immediately pre- and post-testing, and used the same 80RM load as determined during 
PRE testing. 
 
REPEATED LOWER-BODY ANAEROBIC ENDURANCE 
Twenty-four and 48 hours after 80RM HS testing, in week 9 (POST), subjects returned to 
the laboratory to repeat 80RM HS attempts.  Upon arrival, blood was collected to assess 
pre-exercise (or, 24-hr recovery) creatine kinase and white blood cells.  Following blood 
collection, subjects consumed one serving of their assigned supplement and then 
performed two progressive warm-up sets on the HS.  The first warm-up set was 
performed for 8-10 repetitions at 50% of PRE-testing 1RM HS load, whereas the second 
warm-up set was performed for 2-3 repetitions at 70% of PRE-testing 1RM HS load.  
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Warm-up sets were separated by one-minute rest periods; a 3-minute rest period was 
provided between the second warm-up set and the full effort 80RM HS attempt.  Blood 
was again collected immediately post-exercise, which was then followed by consumption 
of a post-workout supplement. 
 
BODY COMPOSITION 
All body composition assessments were performed on the same day, following a 12-hour 
fast (water intake was allowed up to one hour prior to testing).  No exercise or diuretic-
enhancing products (e.g., caffeine) were allowed 48 hours prior to testing, and subjects 
were instructed to remain well hydrated prior to testing.  Hydration status was determined 
immediately prior to body composition testing, using specific gravity via handheld 
refractometry (Model CLX-1, precision = 0.001±0.001, VEE GEE Scientific, Inc., 
Kirkland, WA).(73)  Subjects with urine specific concentrations > 1.029 ppm were asked 
to consume 8 fl ozs of drinking water, every 15 minutes, and were retested every 30 
minutes until an acceptable hydration status was achieved.  Subjects with urine specific 
concentrations < 1.005 ppm were asked to pedal slowly on an upright cycle ergometer for 
15 mins and were retested every 30 mins until an acceptable hydration status was 
achieved. 
 
Body mass (BM) was measured using a calibrated clinical scale to the nearest 0.001 kg, 
with subjects wearing only tight-fitting compression shorts; height (HT) was measured to 
the nearest 0.5 cm using a calibrated stadiometer.  Fat mass (FM) and lean body mass 
(LBM) were estimated using dual-energy X-ray absorptiometry (DXA; enCORE
™
 2006, 
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software version 10.50.086, Lunar Prodigy Advance, Madison, WI).  Percent body fat 
(%FAT) was calculated as: %FAT = (FM/BM) x 100.  The sum of lean soft tissue for 
both arms and legs (ALST), as measured by DXA, was used to estimate total body 
skeletal muscle mass (TBMM) from the validated equation of Kim et al.(52): TBMM = 
(1.13 x ALST) – (0.02 x age) + 0.97. 
 
Each day, prior to testing, a quality assurance phantom was performed to ensure 
calibration of the DXA machine.  Subjects were positioned supine on the DXA table, 
subjects' arms extend at their sides and hands pronated and flat on the table.  Subjects' 
HT, BM, sex, date of birth, and race were entered into the software program, total body 
mode was selected for each scan, and scanning thickness was determined by the DXA 
software.  All DXA assessments were conducted, and all DXA machine-provided regions 
of interest (ROIs) were manually checked and adjusted (if necessary) by the same 
researcher.(74)  Test-retest measurements of 11 men and women, measured 24-48 hours 
apart, for %FAT and TBMM resulted in intraclass correlation coefficients (ICC) greater 
than 0.99, and standard error of measurements (SEM) of 0.75% and 0.04 kg, 
respectively.(75) 
   
CLINICAL ADAPTATIONS 
Blood was collected a total of nine times (T1-T9) over the course of the 8-week 
intervention and two weeks of testing.  Specifically, T1 and T4 blood samples were 
collected following a 12-hour fast (water only) and minimum 48-hour abstinence from 
strenuous exercise, immediately following body composition testing during PRE and 
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POST testing to assess blood lipid, hepatic, immune and renal response to the 
intervention.  T2 and T3 blood samples were collected following a 4-hour fast (water 
only), 24 hours after the first and final lower-body exercise session in weeks 1 and 8, 
respectively, to assess creatine kinase and white blood cells.  T6-T9 were collected 
immediately pre- and post-24- and 48-hour repeated 80RM HS testing during POST.  T4 
served as baseline pre-exercise (day 1) of the repeated 80RM HS testing, whereas T5 
served as baseline post-exercise (day 1) and was withdrawn immediately after completion 
of all 1RMPOST and 80RMPOST testing.  Samples were individually labeled by subject 
code, separated by centrifugation, stored in refrigeration, and collected daily by 
Diagnostic Labs of Oklahoma (Oklahoma City, OK) for analysis. 
 
STATISTICS 
Separate 2x4 or 6x4 two-way repeated measures ANCOVAs [time (PRE vs. POST, or 
WEEK 1 vs. WEEK 8, or POSTPRE & POST vs. 24HRPRE & POST vs. 48HRPRE & POST, 
respectively) x group (PLA vs. WPH vs. WPC80+ vs. WPC80)] were used to identify 
main effects for time and time*group interactions.  Subject's baseline upper-body 
strength ranking (i.e., fitness level), as assessed by the ACSM's adapted percentile 
rankings for 1RM BP-to-BM ratio (69), total 8-week relative training volume (kg/min), 
and average 8-week relative protein intake (g/kg/d) were selected as covariates.  For 
statistical analyses of clinical measures, blood collection time also served as a covariate.  
In the event of sphericity violations, Greenhouse-Geisser F-tests were used to analyze 
main effects.  If a significant interaction was observed, the statistical model was 
decomposed by examining simple main effects with one-way repeated measures 
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ANCOVAs across groups and one-way factorial ANCOVAs across time.  In the event of 
a simple main effect, Tukey post-hoc comparisons were performed among groups; all 
pair-wise comparison dependent samples t-tests with Bonferroni corrections were 
performed across time (p≤0.0125).  If there were no interaction, main effects were 
analyzed by collapsing across the non-interacting variable as described above for simple 
main effects.  In the event of significant baseline differences of a dependent variable, as 
determined by multiple one-way ANOVAs, homogeneity-of-slopes tests were used to 
determine the interaction between the covariate and factor, and to assess the 
appropriateness of including the variable as a covariate within subsequent ANCOVA 
analyses.  No other variables (other than those pre-selected) were necessary to serve as 
covariates.  Additionally, no significant (p>0.05) violations of linearity were observed.  
Using an a priori level of significance of p≤0.05 and medium effect size (ES) of 0.25 for 
within-between interactions for repeated measures ANOVA analysis across four groups 
and with statistical power (1-β) of 0.80, total sample size (N) was determined to be 42.  
Post-hoc ANCOVA analysis for fixed effects, main effects and interactions F-tests, using 
p≤0.05 level of significance, N=56, observed partial correlation coefficient of 0.180 
(mean value for FM and TBMM between-groups effects), and three covariates, yielded 
an ES=0.47, critical F statistic of 4.03, and observed 1-β=0.93.  All a priori and post-hoc 
sample size and power analyses were performed using G*Power Version 3.1.1 (Franz 
Faul, Universitat Kiel, Germany), and all statistical analyses were performed using SPSS 
17.0 (SPSS Inc. Chicago, IL). 
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RESULTS 
 
DESCRIPTIVE ANALYSES 
Data from 56 of the 57 subjects that completed the study were used for analysis (PLA, 
n=15; WPH, n=13; WPC80+, n=15; and WPC80, n=13).  Baseline (PRE) measures for 
age, height, percent body fat (%FAT), upper- and lower-body maximal strength (1RM 
BP and 1RM HS, respectively), training status ratio (1RM BP/BM), and relative daily 
energy (CALS), protein (PRO), carbohydrate (CHO) and lipid (FAT) intake did not differ 
(p>0.05) between groups (refer to Table 1, in Appendix A).  A trend toward significant 
differences (p=0.079) at PRE was, however, observed for body mass (BM).  Post hoc 
analyses revealed the effect arose from a significant difference (p=0.050) between 
WPC80 and PLA.  Homogeneity of slopes tests did not, however, conclude BMPRE to be 
a significant (p>0.05) covariate for further analysis.  Additionally, there were no 
significant differences (p>0.05) between groups for any dietary measures assessed for the 
24 hours prior to 1RMPRE and 80RMPRE testing. 
 
NUTRITIONAL ANALYSES 
No significant (p>0.05) interactions or main effects for time (PRE versus the average of 
weeks 1-8) were observed for adjusted average means for relative CALS (kcals/kg/d), 
CHO (g/kg/d or % of kcals/d), or FAT (g/kg/d or % of kcals/d), however, significant 
within-group differences across time (p<0.0125) were observed for CALS (WPC80+ = 
+14.79%; WPC80 = +23.33%), CHO [% of kcals/d (WPC80+ = -13.08%; WPC80 = -
14.45%)] and FAT [g/kg/d (WPC80 = +20.59%); % of kcals/d (WPH = -16.48%); see 
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Table 2, in Appendix A].  Interestingly, no significant (p>0.05) interaction or main effect 
for time was observed for relative PRO (g/kg/d), though within-group differences across 
time were significant (p<0.0125) for each of the three WP groups.  When PRO was 
expressed as a % of kcals/d, however, significant (p<0.05) interaction and main effects 
for time were present, and post hoc comparisons revealed significant differences (p<0.05) 
between PLA and each of the three WP groups. 
 
TRAINING VOLUME 
Adjusted average means for total relative training volume (kg/min) revealed 
PLA>WPC80>WPH>WPC80+, however no differences were observed between groups 
(p>0.05).  Specifically, total relative training volume for PLA (553,956.26±23,003.15 
kg/min) was 1.06% greater than WPC80 (548,128.12±20,143.12 kg/min), 5.43% greater 
than WPH (525,421.60±21,021.41 kg/min), and 8.31% greater than WPC80+ 
(511,454.05±19,511.84 kg/min).  Repeated measures [4x8 (Group x Time)] analysis also 
resulted in no significant (p>0.05) interaction or main effects for time for relative total 
training volume (time: p=0.194, ES=0.030, 1-β=0.465; time*group: p=0.594, ES=0.049, 
1-β=0.485), nor were any significant differences (p>0.05) observed between groups when 
total relative training volume was decomposed by one-way factorial ANCOVAs across 
time (see Figure 5, in Appendix B). 
 
STRENGTH AND ANAEROBIC ENDURANCE 
Results from 1RM, 80RM and repeated 80RM testing are presented in Table 3, in 
Appendix A, and Figures 6 and 7 in Appendix B.  Briefly, there were no significant 
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(p>0.05) interaction effects or observable trends (refer to Figure 7, "Individual responses 
for strength and anaerobic endurance changes from PRE to POST and for repeated 
80RM", in Appendix B) for any of the upper- or lower-body 1RM, 80RM, or repeated 
80RM dependent variables.  Main effects for time were, however, significant (p<0.05) for 
both upper- and lower-body 1RM and 80RM.  Collapsing across groups revealed that all 
groups increased upper- and lower-body 1RM and 80RM significantly (p<0.0125) from 
PRE to POST.  No significant (p>0.05) main effect for time was observed for repeated 
lower-body 80RM, though.  Collapsing across groups did, however, reveal a significant 
(p<0.0125) within-group effect for WPC80+, between repeated 80RM reps completed 
during POST and 24 hours post-testing (24HR; +15.56%). 
 
BODY COMPOSITION 
Body composition results and individual response graphs are presented in Table 4, in 
Appendix A, and Figures 8 and 9 in Appendix B.  Notably, post hoc analyses revealed 
no significant differences (p>0.05) between changes observed in PLA versus any of the 
three WP groups (or, between WP groups), except for changes in FM and %FAT between 
PLA and WPH [+0.861 kg (p=0.057) and +0.640%, versus -1.126 kg and -1.601%, 
respectively].  Similarly, though no significant (p>0.05) interaction effects were observed 
for changes in LBM or TBMM, and all groups significantly (p<0.0125) increased LBM 
and TBMM from PRE to POST, individual response plots would seem to indicate that 
WPH provided the most consistent positive response across these two variables (92.31% 
and 100.00% positive responders for changes in LBM and TBMM, respectively). 
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CLINICAL MEASURES 
12-Hour Fasted (PRE versus POST): Changes in 12-hour fasted blood lipids, from PRE 
to POST, revealed no significant (p>0.05) interactions or main effects for time, and no 
significant between- or within-group changes (p>0.05 and p>0.0125, respectively) when 
collapsed across time and group (see Table 5 in Appendix A).  Similarly, group rankings 
based upon percent of within-group subjects responding favorably to the intervention 
(histograms not shown) provided no discernable trends other than WPC80+ and WPC80 
possibly yielding the most consistent favorable and unfavorable responses, respectively, 
across all blood lipids.  However, no group achieved favorable responder rates of greater 
or less than 76.9%  or 23.1% (WPH for TC and TC:HDL ratio, respectively) for any of 
the blood lipids measured. 
 
Results for 12-hour fasted, PRE versus POST, changes for blood glucose (GLUCOSE), 
urea nitrogen (BUN), creatinine, BUN:creatinine ratio, creatine kinase (CK) and total 
white blood cells (WBC) are presented in Table 6, in Appendix A, and Figure 10, in 
Appendix B.  No significant (p>0.05) interactions or main effects for time were observed 
for any of the dependent variables assayed, with the exception of a significant interaction 
effect for BUN (p=0.027) and a trend toward significance for BUN:creatinine (p=0.093) 
and WBC (p=0.065).  Collapsing across time and treatment revealed that all groups 
significantly decreased creatinine (p<0.0125).  Also, a significant and non-significant 
trend for between-group differences was observed for WPH versus WPC80 (BUN: 
p<0.05; BUN:creatinine: p=0.085).  Similarly, non-significant trends were observed for 
WBC, both between WPH and WPC80+ (p=0.075), and from PRE to POST for WPC80+ 
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(p=0.056). 
 
24-Hour Exercise Response (Week 1 versus Week 8): All groups, except WPH (p=0.093), 
realized a significant (p<0.0125) decrease in CK from week 1 versus 8 for 24-hour 
response to the first and final lower-body workout (see Table 7, in Appendix A, and 
Figure 11 in Appendix B).  However, there were no significant (p>0.05) between-group 
effects observed, despite WPC80+ reducing CK response by over 1.53x the change 
observed in WPH (p=0.073).  Similarly, there were no significant (p>0.05) interactions or 
main effects for time for WBC; though, collapsing across time revealed a non-significant 
trend comparing week 1 to 8 for WPC80 (p=0.067). 
 
Repeated 80RM (80RMPOST versus 80RM24 versus 80RM48): Though a positive linear 
trend for time, across all groups, was observed for WBC and CK for pre- and post-
repeated 80RM tests, no significant (p>0.05) between-group differences, and no 
significant (p>0.05) interaction or main effects for time were observed (see Table 8, in 
Appendix A, and Figure 12, in Appendix B).  Instead, only a non-significant (p=0.077) 
difference between PLA and WPH was observed for WBC at timepoint 2.  All pre-testing 
WBC values for 80RMPOST, 80RM24 and 80RM48 were significantly different (p<0.0125) 
from all post-testing values, with the exception of timepoint 2 vs. 5, for WPC80 
(p>0.0125).  However, there were no significant differences across time (p>0.0125) for 
pre- or post-testing responses (e.g., pre-80RMPOST versus pre-80RM24) within any of the 
four groups; only non-significant trends for timepoints 3 vs. 5 and 1 vs. 5 for WPH 
(p=0.072) and WPC80 (p=0.105), respectively.  Interestingly, for within-group CK 
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response, timepoints 1 and 2 generally did not differ significantly (p>0.0125) from 
timepoints 3-6 within any group.  A significant effect from timepoint 2 vs. 4 (p<0.0125) 
and trends from 2 vs. 3 (p=0.080), 2 vs. 5 (p=0.080) , and 4 vs. 5 (p=0.096) were, 
however, observed for WPC80+.  Additionally, PLA realized a significant (p<0.0125) 
decrease in CK from timepoint 4 vs. 5, and trended toward significant differences for 
timepoints 3 vs. 5 (p=0.093) and 4 vs. 6 (p=0.060). 
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DISCUSSION 
 
This is the first study to compare the effects of different forms of a whey protein (WP) on 
the physiological response to chronic (4 d/wk x 8 wks), heavy resistance exercise.  It was 
hypothesized that the addition of 60 g/d protein (PRO; as one of three forms of WP), 
versus carbohydrate (PLA), would support greater increases in muscle mass (TBMM) 
and reductions in fat mass (FM) in previously trained young men.  Furthermore, it was 
postulated that provision of an extensively hydrolyzed 80% whey protein concentrate 
(WPH) would accentuate gains in TBMM and reductions in FM compared to its native 
80% whey protein concentrate (WPC80).  This hypothesis was based upon acute data that 
has previously shown improved exercise recovery and increased insulin response, as well 
as a trend toward greater muscle protein synthesis arising from the use of extensive 
hydrolysates versus their native PRO source.(11, 13, 66)  A final hypothesis was that a 
modified WPC80, containing significantly higher concentrations (100x greater than 
native WPC80) of the antioxidant and immune supporting PRO fraction, lactoferrin 
(WPC80+) (48, 76), may elicit greater gains in TBMM, as well as improve clinical and 
training response to repeated anaerobic endurance bouts compared to WPC80.  Instead, 
the current study revealed that, in previously trained, healthy young men (18.89±0.70 
%FAT; 21.40±0.36 yrs),  eight weeks of heavy resistance training plus twice daily WP, 
regardless of WP form or molecular weight distribution, was no more effective than PLA 
at increasing TBMM, lean body mass (LBM), upper- and lower-body strength (1RM BP 
and 1RM HS, respectively) and anaerobic endurance (80RM BP and 80RM HS, 
respectively), and response to repeated 80RM bouts.  Similarly, no significant between-
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group effects were observed for TBMM, LBM, 1RM, 80RM or repeated 80RM for the 
three WPs under investigation.  WPH did, however, result in greater FM loss and 
reduction of percent body fat (%FAT) versus PLA, and WPH also appeared to improve 
nitrogen retention and/or metabolic efficiency compared to WPC80 and WPC80+.   
 
The non-significant effects observed between consuming a WP or carbohydrate (CHO) 
placebo are only surprising if the existing literature is not differentiated between studies 
involving trained versus untrained subjects.  For example, both Willoughby et al. (17) 
and Andersen et al. (34) have reported that 10-14 weeks of pre- and post-exercise PRO 
intake (20-25 g/serving/d), combined with ≥ 3 d/wk heavy resistance training in 
previously untrained males, was significantly more effective than CHO at increasing 
body mass (BM), fat-free mass, thigh mass, upper- and lower-body 1RM (17), peak 
power output, muscle cross sectional area (34), myofibrillar protein, and markers of 
muscle protein synthesis and anabolism.(17)  Comparatively, the effects of PRO versus 
CHO in previously resistance trained males is less positive.  For example, Cribb et al. 
(77) reported that heavy resistance training plus 1.5 g/kg/d x 11 weeks supplemental 
whey protein isolate (WPI) or CHO provided comparable changes on BM, LBM, FM, 
%FAT, and muscle hypertrophy (as assessed by muscle biopsies) in previously resistance 
trained, young men.  However, an accentuated (p<0.05) response from WPI versus CHO 
on upper- and lower-body 1RM, as well as vastus lateralis myofibrillar content was 
observed.  Kerksick et al. (18) similarly reported no significant differences (p>0.05) for 
changes in BM, FM, or %FAT between previously resistance trained male subjects 
consuming an additional 48 g/d CHO or PRO (as a WP and casein blend) while involved 
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in 4 d/wk x 10 weeks heavy resistance training.  Instead, only a significant difference 
between groups for changes in LBM was observed (PRO = +3.10%; CHO = 0.00%; 
p<0.05).  Also, Kerksick et al. (18) reported that both PRO and CHO realized significant 
improvements over time in upper- and lower-body 1RM and 80RM; however, these 
changes were not significantly different between groups. 
 
Similar (significant) main effects for time, but no significant group interactions for 
TBMM, and upper- and lower-body 1RM and 80RM were also observed in the current 
study, which may be the result of the same linear, periodized training program used in 
both the Kerksick et al. (18) and the current investigation.  Therefore, compared to the 
results observed by Cribb et al. (77) it could be argued that, 1) the training program 
selected for the current study did not provide ample total or within-phase time to achieve 
between-group significance for muscle hypertrophy and strength in previously trained 
men [Weeks 1-4 (hypertrophy) + Weeks 5-8 (strength)], or 2) the current study did not 
provide adequate amounts of PRO to achieve some minimum necessary difference in 
g/kg/d PRO between the PLA and WP treatments [Cribb et al.(77): CHO group = 1.6 
g/kg/d vs. PRO group = 3.1 g/kg/d; current investigation: PLA = 1.575 g/kg/d vs. WPH = 
1.904 g/kg/d vs. WPC80+ = 1.971 g/kg/d vs. WPC80 = 1.846 g/kg/d; refer to Table 2].  
In neither argument, though, is the respective affect particularly relevant to assessing the 
effects of WP source or molecular composition on physiological adaptations to resistance 
training.  It is worth discussing, however, that the second argument posed above may 
challenge conclusions proposed by Hoffman et al.(63)  Specifically, "that protein intakes 
at or above the recommended levels for strength and power athletes (1.2-1.7 g/kg/d) do 
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not augment lean body mass, power, or strength gains."  Sample size notwithstanding 
[Cribb et al. (77): CHO group n = 7 vs. PRO group n = 5], it is more unlikely that the 
significant between-group 1RM differences observed by Cribb et al.(77) was the product 
of WP type (i.e., WPI) instead of a potential added benefit of doubling subjects' PRO 
intake, regardless of the fact that all groups were found to consume PRO intakes "at or 
above recommended levels."  If the use of WPI was indeed the significant contributing 
factor, which is the only other explanation if the conclusion by Hoffman et al.(63) is 
correct, then at minimal, a trend toward significance for differences between PLA and 
WPC80 or WPH would have been expected within the current investigation.  Thus, it is 
recommended that future resistance training interventions, in previously trained men, 
attempt to compare the effects of graded relative doses of PRO versus CHO to identify if 
(and at what amount) a minimal g/kg/d of PRO difference is required to elicit significant 
between-group effects on measures of muscle hypertrophy, LBM, and upper- and lower-
body strength and muscular endurance.  Also, if any benefit exists, at what chronic dose 
of PRO is a threshold reached by which no additional performance or body composition 
benefit realized. 
 
Another explanation for the mostly paired effects observed between PLA and each of the 
WP treatments in the current investigation, may be found within work involving primed 
constant infusion to assess muscle protein synthesis (MPS) in response to resistance 
exercise.  Collectively, as presented in a recent review paper by Burd et al. (1), MPS 
appears to peak between 3-4 hours post-exercise in previously trained subjects.  In 
previously untrained muscle, MPS appears to peak between 16 and 28 hours post-
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exercise.  The implications such findings have on the observed outcomes within the 
current study are that, aside from the twice daily supplementation guidelines, no 
additional controls were placed on the subjects' diets.  Most importantly, there was no 
mandatory fasting period in the hours following each exercise session or the non-training 
day doses.(7)  Thus, it is plausible that the suppression of muscle protein catabolism 
arising from a marked increase in insulin (provided by PLA), if subsequently followed by 
a protein-containing meal or snack within 3-4 hours post-exercise, may have significantly 
augmented the corresponding net protein balance response to exercise plus PLA.(78)  In 
other words, it is possible that by attempting to observe "real world" results and not place 
tight controls on subjects' diets that, instead, the control group (PLA) itself became little 
more than a fourth PRO treatment group (i.e., CHO + PRO).  An underlying assumption 
to this hypothesis, though, is that WP provided a satiating effect in the hours immediately 
following its ingestion.(79)  If indeed such an affect did occur, there were no between-
group effects observed on measures of relative energy intake (kcal/kg/d) that may readily 
substantiate this hypothesis.  In fact, subjects in WPC80+ and WPC80 realized 
significant increases in energy intake from PRE to POST, while energy intake for both 
PLA and WPH increased slightly, but non-significantly (refer to Table 2).  Hoffman et 
al.(63) did, however, report what could be concluded as a satiating effect in response to 
PRO timing occurring immediately pre- and post-resistance training as opposed to when 
PRO is consumed several hours distal to training.  Specifically, subjects consuming a 42 
g PRO supplement (predominantly composed of hydrolysate) immediately pre- and post-
exercise realized a non-significant (p>0.05) reduction in energy intake (-11.5% kcals/kg/d 
and -10.5% kcals/d), whereas subjects consuming the PRO supplement at times distal to 
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training had no change in relative or absolute energy consumed over the 10-week 
intervention.  What makes this difference interesting, though, is that the pre/post 
supplement intervention did not promote a significant increase in PRO intake (+20.0% 
g/kg/d and +16.6% g/d) from week 0 to week 10.  A significant increase in relative and 
absolute PRO was, however, observed in the other PRO group (+62.9% g/kg/d and 
+59.0% g/d).  Speculatively, it is possible that when adequate amounts of PRO or 
essential amino acids are not consumed within a specific post-exercise period of time, 
increased nitrogen intake (or some nitrogen seeking response) may arise as a secondary 
outcome (or primary trigger) of the previously well-described behavioral compensatory 
response to exercise-induced increases in energy expenditure.(80)  In partial support, 
even though subjects in PLA were shown to be consuming an adjusted average of 1.452 
g/kg/d PRO at baseline, the group's adjusted average intake throughout the 8-week 
intervention increased to 1.575 g/kg/d (+8.47%; p>0.0125).  Thus, it is possible the PLA 
group may have benefited from a combined effect of prior insulin stimulation and added 
PRO ingestion/seeking within the 3-4 hours post-exercise.  Or, the high relative PRO 
intake across all groups may just provide additional support to the aforementioned 
conclusion by Hoffman et al.(63) regarding no augmented effects arising between groups 
consuming adequate amounts of PRO. 
 
Regardless of daily PRO intake or nutritional variables that were not adequately 
controlled, acute data (11, 13, 66) would seem to support the hypothesis that WP form or 
molecular distribution may affect adaptations to chronic resistance training.  For 
example, Buckley et al. (66) reported that, compared to native WPI, 25 g of an 
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extensively hydrolyzed WPI, consumed 3x within a 24-hour period following a maximal 
eccentric exercise bout, significantly improved recovery time on measures of peak 
isometric torque in previously sedentary males.  Contrary to those findings, no significant 
differences in repetitions or blood measures were observed in the current investigation 
involving previously trained subjects.  A time effect was, however, observed for 
WPC80+ between days 1 and 2 (+15.56% repetitions on day 2 vs. day 1; p<0.0125), 
though subject effort as opposed to any direct benefit specific to the WP itself may have 
caused this lone difference within- or between-groups for repeated 80RM tests.  The 
observed, significant increase in post-exercise blood creatine kinase, from day 1 vs. 2 for 
WPC80+, would seem to support this conclusion (refer to Table 8 and Figure 12).  
Interestingly, comparison of groups does seem to indicate supplementation with WPH 
may have elicited less variability between repeated 80RM bouts (see Figure 6c.).  This 
observational trend was not, however, represented by a correspondingly significant 
increase in training volume over the 8-week intervention, as may have been expected to 
occur if non-significant improvements in recovery culminated over time.  Notably, no 
significant differences were observed between PLA or any of the WP groups for repeated 
80RM bouts, which is in disagreement with the results observed by Hoffman et al.(64)  
There are two plausible explanations  for these differences: 1) subjects in the Hoffman et 
al. (64) study were intercollegiate football players or competitive powerlifters, and 
therefore less likely than recreational weight lifters to deviate from putting forth maximal 
effort on every exercise attempt, and 2) the repeated exercise protocol used by Hoffman 
et al.(64) was of a multi-set design, and thus may be a more valid model to replicate in 
future studies than the single exhaustive set design as was used in the current 
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investigation. 
 
Acute data from Koopman et al. (13) recently reported 25-50% greater total plasma 
amino acid concentrations (p<0.01) and a trend (p=0.10) toward a greater incorporation 
rate of amino acids into skeletal muscle arising from the ingestion of 35 g of casein 
hydrolysate versus native casein in healthy, but elderly men (64±1 yrs).  In fact, similarly 
related acute data provides some evidence that, versus native WP, extensively hydrolyzed 
WP, or WP explicitly manufactured to be high in specific fractions may offer improved 
effects on body composition response to resistance training.(10-12, 29, 30, 35, 81-84)  
For example, Power et al. (11) presented data that revealed a 43% greater 3-hour area 
under the curve and 28% greater peak insulin response in healthy male volunteers 
(22.4±0.48 yrs) after consuming 45 g of a WPH (similar to the WPH used in the current 
investigation) versus WPI.  Therefore, it is not unreasonable to postulate that if greater 
plasma amino acid concentrations and insulin responses occur acutely in response to 
WPH versus native WP, then any summating of differences on net protein balance may 
be able to be observed grossly over time.  In the present investigation, however, no 
significant differences for either TBMM or LBM were observed between WPH and 
WPC80.  However, 12-hour fasted blood data does offer some evidence that WPH may 
have provided higher nitrogen retention than WPC80 (or WPC80+).(37, 85)  Specifically, 
fasting blood urea nitrogen (BUN) was significantly reduced in WPH and increased in 
WPC80 [WPH: -2.760 mg/dL (-18.064%) vs. WPC80: +2.128 mg/dL (+16.908%); 
p<0.05], and a corresponding trend was observed between groups for BUN:creatinine 
ratios from PRE to POST [WPH: -0.920 (-6.195%) vs. WPC80: +2.886 (+23.346%); 
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p=0.085].  Furthermore, though all groups significantly reduced PRE to POST fasted 
blood creatinine, POST values differed significantly between WPH and WPC80+ (WPH: 
0.911±0.030 mg/dL vs. WPC80+: 1.062±0.027 mg/dL; p<0.05), and WPH provided the 
greatest absolute reduction relative to the other WP groups though no between-group 
differences reached significance (WPH - WPC80 = -51.24%; WPH - WPC80+ = -
55.37%; see Table 6).  However, since post-prandial BUN and creatinine response to 
PRO feeding was not assessed in this investigation, it is unwarranted to draw any specific 
conclusions from the observed differences noted above. 
 
Regardless of a possible improvement in nitrogen retention from WPH, based upon 
fasted blood data, there were no real differences observed between WP groups for 
TBMM.  However, it would be premature to assume that since no significant differences 
were observed (for TBMM) in this trial, that similar effects can be expected from 
combined resistance training and WP of any source or molecular distribution.  One 
limitation to this assumption is the lack of dietary controls applied to this investigation.  
For example, a significant increase in total energy intake was observed in both WPC80 
[+6.030 kcal/kg/d (+23.325%); p<0.0125] and WPC80+ [+4.086 kcal/kg/d (+14.793%); 
p<0.0125], versus WPH [+0.996 kcal/kg/d (+3.415%); p>0.0125].  At an adjusted 
baseline BM of 83.471±1.511 kg for WPC80 and 82.261±1.572 kg for WPH, and a 6.030 
and 0.996 kcal/kg/d average increase in energy intake during the 8-week intervention for 
WPC80 versus WPH, respectively, a total 8-week caloric surplus of 23,598.30 kcals for 
subjects in WPC80 versus WPH would have occurred to support changes in TBMM.  The 
significant PRE to POST increase in BM that was observed for both WPC80 and 
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WPC80+, but not WPH, may provide evidence to support this hypothesis.  [NOTE: 
Including energy intake as a fourth covariate was assessed and deemed unnecessary; in 
fact, its inclusion increased the ANCOVA model sum of squared errors and thus was not 
included as a covariate for analyses.]  Similarly, the PRO intervention amongst the three 
WP groups resulted in a 28.92% and 14.63% greater increase in g/kg/d PRO for WPC80 
and WPC80+ versus WPH.  It is therefore recommended that future research in this area 
include tighter dietary controls to decrease the influence potentially confounding 
variables may have on more accurately assessing the research question.  
 
Though no significant effects were observed between WP groups on measures of TBMM 
or exercise performance, WPH did appear to significantly affect body fatness.  
Specifically, WPH reduced FM and %FAT by -5.42% and -1.601%, respectively 
(p<0.0125), which resulted in FM and %FAT losses for WPH being approximately 4x 
and 1.4x greater than was observed for WPC80, and 13.8x and 3.2x greater than 
WPC80+ (WPC80: -1.325% and -0.672%; WPC80+: -0.474% and -0.379%; p>0.0125).  
Though these changes were not significantly different between WP groups (p>0.05), the 
effects on FM and %FAT between WPH versus PLA did achieve significance (p<0.05).  
Since there was neither a significant difference in TBMM (e.g., hyperaminoacidemia-
induced MPS) or energy intake (e.g., satiety-induced deficit) between WPH and PLA, 
there is little supporting evidence to readily explain this effect.  It is possible that, as has 
been observed in rodents, the high β-lactoglobulin concentration present in the WPH may 
have influenced the loss of fat tissue.(35)  Similarly, leucine has recently been shown to 
increase mitochondrial mass, oxygen consumption, and gene expression in human 
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myocytes and adipocytes, and could then theoretically have an impact on lipid 
metabolism that elicit chronic changes in total fat mass.(86)  However, if indeed β-
lactoglobulin or leucine concentrations were significant contributing factors, then similar 
fat loss would have been expected from all WP groups.  That is, unless there is a specific 
peptide fragment within β-lactoglobulin that is responsible for promoting fat loss and 
happened to be more readily available from WPH, and/or if a greater leucine response 
was elicited as a result of WPH delivery, respectively.  Similarly, glucagon-like peptide-1 
(GLP-1) and glucagon have each been shown to increase, and the insulin:glucagon ratio 
to decrease significantly in response to WP, but to date there is no data to show a marked 
response difference between native WP and its hydrolysate.(10, 29, 83)  For example, 
Aziz et  al. (83) reported that when WP or WPH was provided to rats, following induced 
GLP-1 agonism, plasma amino acid removal and free fatty acid presence increased 
significantly by 30 and 60 minutes post-prandial.  These results led the researchers to 
conclude that peptides arising from digestion (or delivered as hydrolysates) may 
significantly affect metabolic regulation.  In fact, recent evidence suggests that 
gastrointestinal peptides such as GLP-1 and glucose-dependent insulinotropic polipeptide 
(GIP) may have increased metabolic processes that could have contributed to the FM and 
%FAT differences observed between WPH and PLA.(87, 88)  If correct, greater 
metabolic efficiency involving an increase in amino acid removal from circulation (or 
increased nitrogen retention) would explain the reduced BUN and other observed 
changes in fasted blood data presented earlier.  Further evidence of WP improving 
metabolic response has also recently provided by Hackney et al.(89)  These researchers 
reported that consuming WP immediately after a heavy resistance training bout 
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significantly lowered the non-protein respiratory exchange ratio (RER) and significantly 
increased resting energy expenditure (REE) in the 24- and 48-hours following exercise.  
In fact, the REE effect 24-hours after exercise was found to be significantly different 
from the effect observed after consuming an isocalorically matched CHO.  Another 
possible explanation for the observed difference in fat loss may simply be the WPH 
group's dietary changes.  Covariate adjusted nutritional analysis (Table 2) revealed that 
the WPH group significantly reduced relative lipid intake (% of total kcals), which cannot 
be ruled-out as a contributing factor affecting fat loss. (90). 
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CONCLUSION 
 
Unique to the results observed from this investigation, versus previous studies that have 
assessed the chronic effects of heavy resistance training  in combination with 
supplemental whey protein (WP) versus carbohydrate (CHO), is the present trial's use of 
ANCOVA analysis to address the impact selected covariates may have had on the 
primary dependent variables of interest – body composition, strength, muscular 
endurance, and various blood measures indicative of adaptation.  Thus, hopefully 
providing more confidence in the conclusions drawn from the observed differences 
within and between groups.  Specifically, baseline (PRE) upper-body strength-to-body 
mass status (1RM BP/BM), and total relative training volume (kg/min) and average 
relative protein intake per day (g/kg/d) for the 8-week intervention were pre-selected 
covariates used across all analyses. 
 
In summary, the current data provides evidence to support the hypothesis that WP source 
and molecular distribution affects the physiological response to an 8-week heavy 
resistance training program in previously trained, healthy adult men (18-35 yrs).  Most 
notably, an extensively hydrolyzed 80% whey protein concentrate (WPH), providing 
greater than 80% of the contained protein fractions as weighing ≤ 1 kD in molecular 
weight, appeared to provide a superior body composition and fasted blood analyte 
response versus its native 80% whey protein concentrate source (WPC80) or a high 
lactoferrin-containing 80% whey protein concentrate (WPC80+) provided by different 
supplier.  Specifically, the WPH significantly reduced fat mass and percent body fat, and 
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appeared to improve nitrogen retention (or uptake), while achieving a statistically similar 
increase in lean body mass and muscle mass as provided by the other WP supplements or 
a CHO placebo (PLA).  However, WP form or molecular distribution provide no added 
or differential effect on changes in upper- and lower-body muscular strength or 
endurance, compared to CHO or amongst WP groups. 
 
Whether the difference in fat loss occurred due to factors arising from WPH possibly 
providing a faster rise in, or total amino acid response, an improved insulin:glucagon 
ratio, upregulation of mitochondrial gene expression within myocytes and adipocytes, an 
increased effect on gastrointestinally regulated incretin hormone response or increased 
regulatory peptide availability arising from the WPH, or some other effect unrelated to 
the protein (e.g., dietary factors not being controlled) remains to be elucidated.  However, 
as the first study to assess the chronic effects of WP form and molecular distribution on 
the physiological adaptations to heavy resistance training in a group of likely sports 
nutrition target consumers, this study offers both practical consumer application and 
future research direction that should be further explored. 
 
Therefore, it could be concluded that an extensively hydrolyzed 80% WP may be most 
beneficial to reduce body fat and percent body fat, while simultaneously increasing 
muscle mass, strength and muscular endurance within a relatively short period of time 
(eight weeks).  However, if an increase in body mass, in addition to increasing muscle 
mass, strength and muscular endurance, is more important than a significant reduction in 
body fat or percent body fat within the same short period of time, then it appears any 80% 
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whey protein concentrate will be more effective than an extensive hydrolysate.  It is 
recommended, however, that future studies on this topic utilize tighter dietary controls to 
minimize both PRE to POST within- and between-group differences on dietary intake, as 
well as minimize potentially additive effects on net protein balance that are indirectly 
related to the WP intervention.  Additionally, the effects of WPH on fat mass warrant 
future studies within overweight and obese populations to determine if a similar such 
effect arises in response to ad libitum, controlled and energy-restricted dieting.  Lastly, it 
is recommended that the effects of WP source or molecular distribution be observed 
within 25-45 year-old, previously trained adults to assess if the effects observed within 
the current investigation (involving 94.7% college undergraduates), may be accentuated 
within the context of a group of adults adhering to a more consistent lifestyle and better 
overall dietary habits. 
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APPENDIX A 
 
PLA 15 20.93 0.41 -0.141 -1.479
WPH 13 21.55 0.90 1.829 3.951
WPC80+ 15 21.85 0.89 2.513 7.523
WPC80 13 21.27 0.66 1.727 3.784
TOTAL 56 21.40 0.36 2.213 6.538
PLA 15 178.63 1.68 0.188 -1.190
WPH 13 177.56 1.19 -0.950 -0.224
WPC80+ 15 177.83 1.10 0.813 -0.280
WPC80 13 180.42 1.15 0.103 -1.056
TOTAL 56 178.59 0.66 0.115 -0.586
PLA 15 1.21 0.06 0.149 -0.758
WPH 13 1.23 0.05 -0.763 1.441
WPC80+ 15 1.24 0.04 0.325 -0.494
WPC80 13 1.29 0.07 -0.292 0.153
TOTAL 56 1.24 0.03 -0.074 -0.093
PLA 15 76.21 2.18 0.167 -1.415
WPH 13 79.57 1.77 -0.523 -0.100
WPC80+ 15 78.85 2.24 0.222 -0.875
WPC80 13 83.78 1.62 -0.191 -0.306
TOTAL 56 79.46 1.04 -0.172 -0.858
PLA 15 17.34 1.39 0.628 0.833
WPH 13 21.49 1.05 -0.606 0.269
WPC80+ 15 17.43 1.62 0.177 -1.050
WPC80 13 19.75 1.23 -0.240 -0.503
TOTAL 56 18.89 0.70 -0.133 -0.645
PLA 15 33.17 2.59 -0.049 -0.548
WPH 12 31.75 2.50 0.384 0.760
WPC80+ 15 31.03 3.01 1.433 2.341
WPC80 13 27.43 1.40 0.859 0.905
TOTAL 55 30.92 1.26 0.926 1.190
PLA 15 1.33 0.14 1.101 0.699
WPH 12 1.37 0.12 0.689 -0.507
WPC80+ 15 1.35 0.18 1.913 3.790
WPC80 13 1.16 0.12 2.082 6.068
TOTAL 55 1.31 0.07 1.613 2.993
PLA 15 92.68 5.35 0.288 -0.132
WPH 13 97.87 4.86 -0.097 0.419
WPC80+ 15 97.22 3.60 0.049 1.676
WPC80 13 108.69 6.96 0.016 0.706
TOTAL 56 98.82 2.66 0.306 0.631
PLA 15 161.48 11.75 0.529 -0.651
WPH 13 164.34 7.94 -0.049 -1.004
WPC80+ 15 169.34 7.43 0.314 -0.301
WPC80 13 151.78 13.04 1.198 0.786
TOTAL 56 162.00 5.07 0.485 -0.284
0.193
0.681
1RM HS (Kg)
SKEWNESS 
STATISTIC
KURTOSIS 
STATISTIC
0.825
0.449
0.742
1RM BP (Kg)
PLA = PLACEBO; WPH = WHEY PROTEIN HYDROLYSATE; WPC80+ = HIGH LACTOFERRIN 80% WHEY PROTEIN 
CONCENTRATE; WPC80 = 80% WHEY PROTEIN CONCENTRATE. No significant differences (p >0.05) were observed 
between groups for baseline measures of Age, Height, Training Status [1RM Bench Press (Kg)  / Body Mass (Kg)], Body 
Mass (BM), Percent Body Fat (%FAT), Relative Energy per day (CALS kcals/kg/d), Relative Protein per day (PRO 
g/kg/d), One-Rep Max Bench Press (1RM BP), and One-Rep Max Hack Squat (1RM HS). 
†
WPC80 - PLA (p =0.050).
% FAT
0.801
CALS (kcal/kg/d)
PRO (g/kg/d)
0.079
†
0.111
0.434
TABLE 1. Descriptive statistics at baseline (Unadjusted MEAN±SEM)
N MEAN SEM p -value
AGE (yrs)
HEIGHT (cm)
TRAINING STATUS
BM (Kg)
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MEAN ±SEM MEAN ±SEM MEAN ±SEM MEAN ±SEM
PLA 40.018 2.593 41.576 1.579 1.558 3.893 5.070 0.385 5.151 0.260 0.081 1.598
WPH 29.162 2.401 30.158 1.462 0.996 3.415 3.334 0.357 3.255 0.241 -0.079 -2.370
WPC80+ 27.622 2.230 31.708 1.358 4.086 14.793 * 3.337 0.331 3.290 0.224 -0.047 -1.408
WPC80 25.852 2.268 31.882 1.381 6.030 23.325 * 3.240 0.337 3.370 0.228 0.130 4.012
MEAN ±SEM MEAN ±SEM MEAN ±SEM MEAN ±SEM
PLA 1.452 0.199 1.575 0.126 0.123 8.471 51.156 2.591 50.507 1.806 -0.649 -1.269
WPH 1.330 0.166 1.904 0.105 0.574 43.158 * 45.838 2.399 43.444 1.672 -2.394 -5.223
WPC80+ 1.313 0.148 1.971 0.093 0.658 50.114 * 47.998 2.228 41.721 1.553 -6.277 -13.078 *
WPC80 1.106 0.154 1.846 0.097 0.740 66.908 * 49.460 2.266 42.313 1.579 -7.147 -14.450 *
MEAN ±SEM MEAN ±SEM MEAN ±SEM MEAN ±SEM
PLA 17.323 1.271 16.817 1.052 -0.506 -2.921 25.727 3.162 24.427 1.928 -1.300 -5.053
WPH 17.232 1.177 24.152 0.974 6.920 40.158 *† 21.721 2.928 20.694 1.785 -1.027 -4.728
WPC80+ 16.883 1.093 23.471 0.905 6.588 39.022 *† 17.231 2.720 15.138 1.658 -2.093 -12.147
WPC80 16.343 1.112 23.461 0.920 7.118 43.554 *† 20.900 2.766 18.167 1.686 -2.733 -13.077
MEAN ±SEM MEAN ±SEM MEAN ±SEM MEAN ±SEM
PLA 1.400 0.132 1.387 0.079 -0.013 -0.929 115.840 49.934 105.613 45.557 -10.227 -8.829
WPH 1.198 0.123 1.011 0.074 -0.187 -15.609 140.254 46.234 124.528 42.182 -15.726 -11.213
WPC80+ 1.068 0.114 1.136 0.068 0.068 6.367 111.747 42.943 75.884 39.179 -35.863 -32.093
WPC80 0.918 0.116 1.107 0.069 0.189 20.588 * 114.663 43.672 119.829 39.845 5.166 4.505
MEAN ±SEM MEAN ±SEM MEAN ±SEM MEAN ±SEM
PLA 32.099 2.285 30.388 1.554 -1.711 -5.330 1244.984 138.085 1152.699 93.065 -92.285 -7.413
WPH 35.918 2.116 30.000 1.439 -5.918 -16.476 * 983.481 127.855 1223.523 86.170 240.042 24.407
WPC80+ 34.349 1.965 32.405 1.336 -1.944 -5.660 824.985 118.754 1221.807 80.036 396.822 48.101 *†
WPC80 31.847 1.998 30.777 1.359 -1.070 -3.360 924.003 120.771 1163.923 81.396 239.920 25.965 *
PLA = PLACEBO; WPH = WHEY PROTEIN HYDROLYSATE; WPC80+ = HIGH LACTOFERRIN 80% WHEY PROTEIN CONCENTRATE; WPC80 = 80% WHEY PROTEIN 
CONCENTRATE. Time = Main Effect by Time; Time*Group = Interaction Main Effect; ES = Effect Size; 1-β = Power. Estimated average means adjusted for covariates: Training Status 
Ratio (PRE), Total 8-wk Relative Training Volume (kg/min), and Average 8-wk Relative Protein Intake (g/kg/d). 
¥
AVG WK 1-8 PROTEIN (% of kcals/d) used as covariate to assess 
PROTEIN (g/kg/d). Main effects set at p ≤0.05.*Different from PRE (p ≤0.0125); †Different from PLA (p ≤0.05); ‡Different from WPC80+ (p ≤0.05); §Different from WPC80 (p ≤0.05).
TABLE 2. Changes in dietary intake from baseline (Adjusted MEAN±SEM)
ENERGY (kcal/kg/d)
Time (p =0.170, ES=0.039, 1-β=0.277); Time*Group (p =0.330, ES=0.068, 1-β=0.295)
BASELINE AVG WK 1-8
∆ %∆
PROTEIN (g/kg/d)
¥
Time (p =0.413, ES=0.014, 1-β=0.128); Time*Group (p =0.068, ES=0.136, 1-β=0.589)
BASELINE AVG WK 1-8
∆ %∆
PROTEIN (%  of kcals/d)
Time (p =0.433, ES=0.013, 1-β=0.121); Time*Group (p =0.001, ES=0.277, 1-β=0.947)
BASELINE AVG WK 1-8
∆
Time (p =0.769, ES=0.002, 1-β=0.060); Time*Group (p =0.096, ES=0.123, 1-β=0.531)
Time (p =0.259, ES=0.026, 1-β=0.201); Time*Group (p =0.086, ES=0.127, 1-β=0.551)
BASELINE
Time (p =0.577, ES=0.007, 1-β=0.085); Time*Group (p =0.960, ES=0.006, 1-β=0.067)
BASELINE AVG WK 1-8
∆ %∆
FIBER (g/d)
AVG WK 1-8
FAT (%  of kcals/d)
Time (p =0.218, ES=0.031, 1-β=0.231); Time*Group (p =0.131, ES=0.110, 1-β=0.477)
BASELINE AVG WK 1-8
∆ %∆
FAT (g/kg/d)
%∆
%∆
CARBOHYDRATE (g/kg/d)
Time (p =0.061, ES=0.071, 1-β=0.469); Time*Group (p =0.953, ES=0.007, 1-β=0.069)
BASELINE AVG WK 1-8
∆ %∆
CARBOHYDRATE (%  of kcals/d)
∆
BASELINE
BASELINE AVG WK 1-8
∆ %∆
AVG WK 1-8
∆ %∆
VITAMIN D (IU/d)
Time (p =0.365, ES=0.017, 1-β=0.146); Time*Group (p =0.527, ES=0.045, 1-β=0.199)
CALCIUM (mg/d)
Time (p =0.049, ES=0.079, 1-β=0.509); Time*Group (p =0.027, ES=0.173, 1-β=0.724)
BASELINE AVG WK 1-8
∆ %∆
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MEAN SEM MEAN SEM ∆ %∆ MEAN SEM MEAN SEM ∆ %∆
PLA 87.81 2.23 94.79 2.61 6.98 7.95 * 7.81 0.51 11.04 0.86 3.23 41.32 *
WPH 100.69 2.22 105.43 2.60 4.74 4.71 * 6.70 0.51 8.81 0.85 2.11 31.55 *
WPC80+ 100.98 1.91 107.18 2.25 6.20 6.14 * 7.86 0.44 10.53 0.74 2.68 34.05 *
WPC80 103.80 1.96 109.88 2.30 6.08 5.86 * 7.25 0.45 10.04 0.76 2.78 38.38 *
MEAN SEM MEAN SEM ∆ %∆ MEAN SEM MEAN SEM ∆ %∆
PLA 166.52 8.72 210.85 8.29 44.34 26.63 * 9.97 1.52 25.56 2.82 15.58 156.27 *
WPH 164.17 8.26 203.51 7.86 39.34 23.96 * 8.60 1.44 21.59 2.67 12.99 151.08 *
WPC80+ 170.91 7.50 215.72 7.13 44.80 26.21 * 10.91 1.30 20.57 2.43 9.66 88.52 *
WPC80 141.25 7.68 190.50 7.31 49.25 34.87 * 8.12 1.34 21.46 2.49 13.34 164.36 *
MEAN SEM MEAN SEM MEAN SEM ∆ %∆ ∆ %∆ ∆ %∆
PLA 25.92 2.93 28.17 2.99 25.62 2.64 2.26 8.71 -0.30 -1.14 -2.55 -9.06
WPH 21.40 2.70 20.29 2.75 20.91 2.43 -1.11 -5.20 -0.49 -2.31 0.62 3.05
WPC80+ 20.31 2.46 23.47 2.51 21.49 2.21 3.16 15.56 1.18 5.82 -1.98 -8.43 ¶
WPC80 22.15 2.60 23.93 2.65 21.18 2.34 1.78 8.04 -0.97 -4.38 -2.75 -11.50
PLA = PLACEBO; WPH = WHEY PROTEIN HYDROLYSATE; WPC80+ = HIGH LACTOFERRIN 80% WHEY PROTEIN CONCENTRATE; WPC80 = 80% WHEY PROTEIN CONCENTRATE. 
1RM = One-Repition Maximum; 80RM = Maximum Repitions to Failure at 80% of 1RM; REPEATED 80RM = Repeated 80RM Hack Squat tests occurring 24 and 48 Hours after 80RM POST Hack 
Squat. Time = Main Effect by Time; Time*Group = Interaction Main Effect; ES = Effect Size; 1-β = Power. Estimated average means adjusted for covariates: Training Status Ratio (PRE), Total 
8-wk Relative Training Volume (kg/min), and Average 8-wk Relative Protein Intake (g/kg/d). Main effects set at p ≤0.05.*Different from PRE (p ≤0.0125); †Different from PLA (p ≤0.05); 
‡
Different from WPC80+ (p ≤0.05); §Different from WPC80 (p ≤0.05); ¶24HR Different from POST  (p ≤0.0125).
24HR-POST
80RM HACK SQUAT (reps)
PRE POST
REPEATED 80RM HACK SQUAT (reps)
Time (p=0.837, ES=0.003, 1-β=0.067); Time*Group (p=0.438, ES=0.060, 1-β=0.322)
Time (p =0.005, ES=0.154, 1-β=0.816); Time*Group (p =0.731, ES=0.027, 1-β=0.130)
1RM BENCH PRESS (Kg)
1RM HACK SQUAT (Kg)
Time (p =0.001, ES=0.208, 1-β=0.936); Time*Group (p =0.853, ES=0.016, 1-β=0.096)
48HR-POST
POST-PREPOST-PRE
POST
POST
24HR 48HR 48HR-24HR
Time (p =0.014, ES=0.120, 1-β=0.710); Time*Group (p =0.439, ES=0.054, 1-β=0.236)
PRE
PRE POST
TABLE 3. Changes in strength and anerobic endurance from PRE to POST and for repeated 80RM (Adjusted MEAN±SEM)
POST-PREPOST-PRE
PRE POST
80RM BENCH PRESS (reps)
Time (p =0.002, ES=0.179, 1-β=0.879); Time*Group (p =0.800, ES=0.021, 1-β=0.110)
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MEAN ±SEM MEAN ±SEM
PLA 70.777 1.729 73.126 1.699 2.349 3.319 *
WPH 82.261 1.572 82.902 1.545 0.641 0.779
WPC80+ 82.225 1.477 83.662 1.451 1.437 1.748 *
WPC80 83.471 1.511 85.036 1.484 1.565 1.875 *
MEAN ±SEM MEAN ±SEM
PLA 9.462 1.236 10.323 1.193 0.861 9.100
WPH 18.949 1.124 17.823 1.084 -1.126 -5.942 *†
WPC80+ 16.048 1.056 15.972 1.019 -0.076 -0.474
WPC80 17.060 1.080 16.834 1.042 -0.226 -1.325
MEAN ±SEM MEAN ±SEM
PLA 59.100 1.541 60.551 1.512 1.451 2.455 *
WPH 60.511 1.401 62.396 1.374 1.885 3.115 *
WPC80+ 63.538 1.316 65.113 1.291 1.575 2.479 *
WPC80 63.639 1.346 65.500 1.320 1.861 2.924 *
MEAN ±SEM MEAN ±SEM
PLA 13.688 1.376 14.328 1.316 0.640 4.676
WPH 23.092 1.251 21.491 1.196 -1.601 -6.933 *†
WPC80+ 19.145 1.175 18.766 1.124 -0.379 -1.980
WPC80 20.374 1.202 19.702 1.149 -0.672 -3.298
MEAN ±SEM MEAN ±SEM
PLA 34.241 1.099 35.311 1.086 1.070 3.125 *
WPH 35.276 0.999 36.581 0.987 1.305 3.699 *
WPC80+ 36.991 0.938 38.440 0.927 1.449 3.917 *
WPC80 37.186 0.960 38.707 0.948 1.521 4.090 *
TABLE 4. Changes in body composition from PRE to POST (Adjusted MEAN±SEM)
%∆
PRE
POST
∆ %∆
PLA = PLACEBO; WPH = WHEY PROTEIN HYDROLYSATE; WPC80+ = HIGH 
LACTOFERRIN 80% WHEY PROTEIN CONCENTRATE; WPC80 = 80% WHEY PROTEIN 
CONCENTRATE. %FAT = Percent Body Fat. Time = Main Effect by Time; Time*Group = 
Interaction Main Effect; ES = Effect Size; 1-β = Power. Estimated average means adjusted for 
covariates: Training Status Ratio (PRE), Total 8-wk Relative Training Volume (kg/min), and 
Average 8-wk Relative Protein Intake (g/kg/d). Main effects set at p ≤0.05.*Different from PRE 
(p ≤0.0125); †Different from PLA (p ≤0.05); ‡Different from WPC80+ (p ≤0.05); §Different from 
WPC80 (p ≤0.05).
PRE
Time (p =0.037, ES=0.086, 1-β=0.558); Time*Group (p =0.032, ES=0.162, 1-β=0.699)
Time (p =0.009, ES=0.132, 1-β=0.763); Time*Group (p =0.818, ES=0.019, 1-β=0.106)
∆
% FAT
Time (p =0.845, ES=0.001, 1-β=0.054); Time*Group (p =0.272, ES=0.076, 1-β=0.335)
Time (p =0.093, ES=0.057, 1-β=0.391); Time*Group (p =0.048, ES=0.148, 1-β=0.645)
%∆
Time (p =0.086, ES=0.059, 1-β=0.405); Time*Group (p =0.919, ES=0.010, 1-β=0.079)
POST
BODY MASS (Kg)
FAT MASS (Kg)
LEAN BODY MASS (Kg)
PRE
∆ %∆
%∆
∆
POST
TOTAL BODY SKELETAL MUSCLE MASS (Kg)
PRE POST
PRE POST
∆
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MEAN ±SEM MEAN ±SEM
PLA 152.273 9.301 155.010 8.410 2.737 1.797
WPH 161.689 8.456 154.356 7.646 -7.333 -4.535
WPC80+ 150.768 7.943 154.335 7.182 3.567 2.366
WPC80 162.725 8.124 163.246 7.345 0.521 0.320
MEAN ±SEM MEAN ±SEM
PLA 48.076 4.299 52.368 3.664 4.292 8.928
WPH 58.500 3.909 55.163 3.331 -3.337 -5.704
WPC80+ 55.039 3.672 55.779 3.129 0.740 1.345
WPC80 57.828 3.755 55.129 3.200 -2.699 -4.667
MEAN ±SEM MEAN ±SEM
PLA 87.606 12.362 101.322 10.419 13.716 15.656
WPH 86.134 11.239 86.750 9.473 0.616 0.715
WPC80+ 94.214 10.557 88.339 8.898 -5.875 -6.236
WPC80 100.073 10.797 95.411 9.101 -4.662 -4.659
MEAN ±SEM MEAN ±SEM
PLA 86.732 7.441 82.362 6.819 -4.370 -5.039
WPH 85.857 6.766 81.825 6.200 -4.032 -4.696
WPC80+ 76.876 6.355 80.994 5.824 4.118 5.357
WPC80 84.981 6.500 88.995 5.956 4.014 4.723
MEAN ±SEM MEAN ±SEM
PLA 3.140 0.197 3.012 0.158 -0.128 -4.076
WPH 2.809 0.179 2.833 0.144 0.024 0.854
WPC80+ 2.914 0.168 2.853 0.135 -0.061 -2.093
WPC80 2.967 0.172 3.008 0.138 0.041 1.382
∆ %∆
PRE
∆ %∆
PLA = PLACEBO; WPH = WHEY PROTEIN HYDROLYSATE; WPC80+ = HIGH 
LACTOFERRIN 80% WHEY PROTEIN CONCENTRATE; WPC80 = 80% WHEY PROTEIN 
CONCENTRATE. TC:HDL = Total Cholesterol-to-High Density Lipoprotein ratio. Time = Main 
Effect by Time; Time*Group = Interaction Main Effect; ES = Effect Size; 1-β = Power. Estimated 
average means adjusted for covariates: Training Status Ratio (PRE), Total 8-wk Relative 
Training Volume (kg/min), Average 8-wk Relative Protein Intake (g/kg/d), and Blood Collection 
Time. Main effects set at p ≤0.05.*Different from PRE (p ≤0.0125); †Different from PLA (p ≤0.05); 
‡
Different from WPC80+ (p ≤0.05); §Different from WPC80 (p ≤0.05).
Time (p =0.432, ES=0.013, 1-β=0.121); Time*Group (p =0.196, ES=0.090, 1-β=0.400)
PRE POST
∆ %∆
TABLE 5. Changes in blood lipids from PRE to POST (Adjusted MEAN±SEM)
TOTAL CHOLESTEROL (mg/dL)
Time (p =0.271, ES=0.025, 1-β=0.193); Time*Group (p =0.386, ES=0.059, 1-β=0.263)
PRE POST
POST
∆ %∆
LOW DENSITY LIPOPROTEINS (mg/dL)
Time (p =0.632, ES=0.005, 1-β=0.076); Time*Group (p =0.264, ES=0.077, 1-β=0.340)
PRE POST
∆ %∆
TC:HDL
Time (p =0.818, ES=0.001, 1-β=0.056); Time*Group (p =0.777, ES=0.022, 1-β=0.117)
TRIGLYCERIDES (mg/dL)
Time (p =0.360, ES=0.017, 1-β=0.148); Time*Group (p =0.559, ES=0.041, 1-β=0.187)
PRE POST
 HIGH DENSITY LIPOPROTEINS (mg/dL)
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MEAN ±SEM MEAN ±SEM
PLA 88.660 1.664 88.672 1.792 0.012 0.014
WPH 86.342 1.577 87.305 1.698 0.963 1.115
WPC80+ 89.351 1.414 89.768 1.524 0.417 0.467
WPC80 88.441 1.443 89.057 1.554 0.616 0.697
MEAN ±SEM MEAN ±SEM
PLA 14.898 0.990 14.726 0.947 -0.172 -1.155
WPH 15.279 0.938 12.519 0.898 -2.760 -18.064 *§
WPC80+ 15.238 0.841 15.039 0.805 -0.199 -1.306
WPC80 12.586 0.858 14.714 0.821 2.128 16.908 *
MEAN ±SEM MEAN ±SEM
PLA 1.029 0.041 0.961 0.032 -0.068 -6.608 *
WPH 1.032 0.039 0.911 0.030 -0.121 -11.725 *‡POST
WPC80+ 1.116 0.035 1.062 0.027 -0.054 -4.839 *
WPC80 1.041 0.035 0.982 0.028 -0.059 -5.668 *
MEAN ±SEM MEAN ±SEM
PLA 14.410 0.953 15.308 1.061 0.898 6.232
WPH 14.851 0.903 13.931 1.005 -0.920 -6.195
WPC80+ 13.795 0.810 14.239 0.902 0.444 3.219
WPC80 12.362 0.826 15.248 0.920 2.886 23.346 *
MEAN ±SEM MEAN ±SEM
PLA 6.585 0.540 6.653 0.452 0.068 1.033
WPH 5.867 0.490 5.186 0.410 -0.681 -11.607
WPC80+ 5.333 0.461 5.979 0.385 0.646 12.113
WPC80 5.597 0.470 6.061 0.393 0.464 8.290
MEAN ±SEM MEAN ±SEM
PLA 246.572 41.643 212.613 39.104 -33.959 -13.772
WPH 192.281 39.275 195.987 36.881 3.706 1.927
WPC80+ 285.247 35.757 191.820 33.577 -93.427 -32.753 §PRE
WPC80 140.026 36.315 125.897 34.101 -14.129 -10.090
PLA = PLACEBO; WPH = WHEY PROTEIN HYDROLYSATE; WPC80+ = HIGH LACTOFERRIN 80% 
WHEY PROTEIN CONCENTRATE; WPC80 = 80% WHEY PROTEIN CONCENTRATE. 
BUN:CREATININE = Urea Nitrogen-to-Creatinine ratio. Time = Main Effect by Time; Time*Group = 
Interaction Main Effect; ES = Effect Size; 1-β = Power. Estimated average means adjusted for covariates: 
Training Status Ratio (PRE), Total 8-wk Relative Training Volume (kg/min), Average 8-wk Relative 
Protein Intake (g/kg/d), and Blood Collection Time. All blood draws under confirmed euhydrated state 
and after a 12-hour fast (water only). Main effects set at p ≤0.05.*Different from PRE (p ≤0.0125); 
†
Different from PLA (p ≤0.05); ‡Different from WPC80+ (p ≤0.05); §Different from WPC80 (p ≤0.05).
%∆
 UREA NITROGEN (mg/dL)
Time (p =0.771, ES=0.002, 1-β=0.059); Time*Group (p =0.027, ES=0.176, 1-β=0.724)
∆ %∆
CREATININE (mg/dL)
Time (p =0.327, ES=0.020, 1-β=0.163); Time*Group (p =0.157, ES=0.104, 1-β=0.442)
TABLE 6. Changes in select blood measures from PRE to POST (Adjusted MEAN±SEM)
GLUCOSE (mg/dL)
Time (p =0.395, ES=0.015, 1-β=0.134); Time*Group (p =0.992, ES=0.002, 1-β=0.056)
PRE POST
∆
%∆
PRE POST
∆ %∆
BUN:CREATININE (ratio)
Time (p =0.539, ES=0.008, 1-β=0.093); Time*Group (p =0.093, ES=0.126, 1-β=0.537)
PRE POST
PRE POST
∆ %∆
WHITE BLOOD CELL COUNT (1000/µL)
Time (p =0.223, ES=0.031, 1-β=0.227); Time*Group (p =0.065, ES=0.139, 1-β=0.598)
PRE POST
∆
Time (p =0.910, ES=0.000, 1-β=0.051); Time*Group (p =0.440, ES=0.055, 1-β=0.236)
CREATINE KINASE (U/L)
PRE POST
∆ %∆
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MEAN ±SEM MEAN ±SEM
PLA 7.020 0.556 7.301 0.478 0.281 4.003
WPH 6.162 0.497 6.327 0.427 0.165 2.678
WPC80+ 6.442 0.471 6.008 0.405 -0.434 -6.737
WPC80 7.097 0.474 5.947 0.407 -1.150 -16.204
MEAN ±SEM MEAN ±SEM
PLA 1276.910 346.884 357.812 69.501 -919.098 -71.978 *
WPH 1044.593 310.067 414.418 62.125 -630.175 -60.327
WPC80+ 1950.151 294.051 353.969 58.916 -1596.182 -81.849 *
WPC80 1458.952 295.618 226.758 59.230 -1232.194 -84.457 *
PLA = PLACEBO; WPH = WHEY PROTEIN HYDROLYSATE; WPC80+ = HIGH LACTOFERRIN 80% WHEY PROTEIN 
CONCENTRATE; WPC80 = 80% WHEY PROTEIN CONCENTRATE. Time = Main Effect by Time; Time*Group = Interaction 
Main Effect; ES = Effect Size; 1-β = Power. Estimated average means adjusted for covariates: Training Status Ratio (PRE), Total 
8-wk Relative Training Volume (kg/min), Average 8-wk Relative Protein Intake (g/kg/d), and Blood Collection Time. Main 
effects set at p ≤0.05.*Different from Week 1 (p ≤0.0125); †Different from PLA (p ≤0.05); ‡Different from WPC80+ (p ≤0.05); 
§
Different from WPC80 (p ≤0.05).
WEEK 1
WHITE BLOOD CELL COUNT (1000/µL)
CREATINE KINASE (U/L)
Time (p =0.024, ES=0.101, 1-β=0.626); Time*Group (p =0.105, ES=0.119, 1-β=0.516)
TABLE 7. Changes in 24-hour WBC and CK response to lower-body training from Week 1 to Week 8 (Adjusted MEAN±SEM)
Time (p =0.715, ES=0.003, 1-β=0.065); Time*Group (p =0.119, ES=0.114, 1-β=0.494)
WEEK 1 WEEK 8
∆ %∆
WEEK 8
∆ %∆
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MEAN ±SEM MEAN ±SEM MEAN ±SEM MEAN ±SEM MEAN ±SEM MEAN ±SEM
PLA 6.597 0.480 10.478 0.701
1
6.778 0.444
2
9.199 0.628
1,3
7.500 0.627
2,4
10.244 0.734
1,3,5
WPH 5.238 0.414 7.852 0.604
1
5.663 0.383
2
8.020 0.541
1,3
6.091 0.540
2,4
8.581 0.632
1,3,5
WPC80+ 6.017 0.404 8.196 0.590
1
5.821 0.374
2
8.293 0.529
1,3
6.002 0.528
2,4
8.106 0.617
1,3,5
WPC80 6.001 0.415 8.533 0.605
1
6.765 0.384
2
8.845 0.542
1,3
6.898 0.541
4
9.236 0.633
1,3,5
MEAN ±SEM MEAN ±SEM MEAN ±SEM MEAN ±SEM MEAN ±SEM MEAN ±SEM
PLA 191.339 39.849 157.276 25.452 235.266 59.417 258.851 63.801
3
182.309 45.194
4
201.649 45.627
5
WPH 202.999 34.519 197.211 22.048 262.242 51.469 287.195 55.267
3
232.851 39.149 249.180 39.524
5
WPC80+ 189.585 32.537 166.547 20.782 299.100 48.514 323.930 52.094
2,3
260.987 36.901 273.996 37.255
5
WPC80 133.208 34.655 170.266 22.134 204.385 51.672 218.383 55.485
3
180.817 39.303 199.052 39.680
5
PLA = PLACEBO; WPH = WHEY PROTEIN HYDROLYSATE; WPC80+ = HIGH LACTOFERRIN 80% WHEY PROTEIN CONCENTRATE; WPC80 = 80% WHEY 
PROTEIN CONCENTRATE. 80RMPOST = Day 1 of repeated 80RM testing; 80RM24 = Day 2 of repeated 80RM testing; 80RM48 = Day 3 of repeated 80RM testing; DAY 
1PRE = Pre-80RMPOST blood draw (T1); DAY 1POST = Post-80RMPOST blood draw (T2); DAY 2PRE = Pre-80RM24 blood draw (T3); DAY 2POST = Post-80RM24 blood draw 
(T4); DAY 3PRE = Pre-80RM48 blood draw (T5); DAY 3POST = Post-80RM48 blood draw (T6); Time = Main Effect by Time; Time*Group = Interaction Main Effect; ES = 
Effect Size; 1-β = Power. Estimated average means adjusted for covariates: Training Status Ratio (PRE), Total 8-wk Relative Training Volume (kg/min), Average 8-wk 
Relative Protein Intake (g/kg/d), and Blood Collection Time. Main effects set at p ≤0.05. 1Different from T1 (p ≤0.0125); 2Different from T2 (p ≤0.0125); 3Different from T3 
(p ≤0.0125); 4Different from T4 (p ≤0.0125); 5Different from T5 (p ≤0.0125); †Different from PLA (p ≤0.05); ‡Different from WPC80+ (p ≤0.05); §Different from WPC80 
(p ≤0.05).
DAY 2POST DAY 3PRE
DAY 1PRE DAY 1POST
TABLE 8. Changes in WBC and CK in response to repeated 80RM bouts (Adjusted MEAN±SEM)
WHITE BLOOD CELL COUNT (1000/µL)
DAY 1PRE DAY 1POST DAY 2PRE
Time (p =0.341, ES=0.022, 1-β=0.211); Time*Group (p =0.607, ES=0.045, 1-β=0.247)
80RMPOST 80RM24 80RM48
Time (p =0.517, ES=0.017, 1-β=0.225); Time*Group (p =0.220, ES=0.081, 1-β=0.660)
DAY 2PRE DAY 2POST
CREATINE KINASE (U/L)
DAY 3POST
80RMPOST 80RM24 80RM48
DAY 3PRE DAY 3POST
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APPENDIX B 
 
 
Figure 1. 
1a.
1b.
1c.
1d.
1e.
1f.
FIGURE 1. Testing and training day schematics . 1a = Body composition testing (PRE and POST); 1b = Strength and anaerobic endurance testing (PRE); 1c = Strength and anaerobic endurance testing 
(POST); 1d = Repeated 80RM testing (POST); 1e = Blood draws to assess 24-hour response to lower-body training (Week 1 and Week 8); 1f = Resistance training days (Weeks 1-8). DXA = Dual-
energy X-ray absorptiometry. 
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Figure 2. 
SETS
REPS
(WKS 1-4 / WKS 5-8)
Barbell Flat Bench Press 3 10-12 / 5-8
Standing Cable Flye 3 10-12 / 5-8
Bent-Over Barbell Row 3 10-12 / 5-8
Wide-Grip Front Lat Pulldown 3 10-12 / 5-8
Seated Front Military Press 3 10-12 / 5-8
Barbell Shrug 3 10-12 / 5-8
Barbell Biceps Curl 3 10-12 / 5-8
Lying E-Z Bar Triceps Extension 3 10-12 / 5-8
Incline Hack Squat 3 10-12 / 5-8
Barbell Romanian Deadlift 3 10-12 / 5-8
Barbell Lunge 3 10-12 / 5-8
Seated Leg Extension 3 10-12 / 5-8
Lying Leg Curl 3 10-12 / 5-8
Seated Calf Raise 3 10-12 / 5-8
Supine Abdominal Crunch 3 20-25
U
PP
E
R
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FIGURE 2. Upper- and lower-body resistance training program .  Subjects 
performed a split-body, linear periodized resistance training program 4x/wk x 
8wks, following a 2-on/1-rest/2-on/2-rest training days per week regimine (e.g., 
Monday-UPPER, Tuesday-LOWER, Wednesday-REST, Thursday-UPPER, 
Friday-LOWER, Saturday-REST, Sundary-REST). A 5-min moderate intensity 
warm-up preceeded each workout. Barbell Flat Bench Press and Incline Hack 
Squat preceeded all other resistance training exercises on Upper- and Lower-
Body training days, respectively. Subjects performed 3 sets x 10-12 and 6-8 
repetitions (REPS) during Weeks 1-4 and 5-8, respectively. All sets were 
instructed to be taken to voluntary muscle failure within the specified number of 
repetitions. Subjects were provided 1- and 2-min rest periods between sets and 
exercises, respectively. All subjects were provided a stopwatch to ensure 
accuracy of rest period duration and to track total workout duration. All 
subjects recorded resistance per set, successfully completed reps, and total 
training time and sets during each training session.
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Figure 3. 
WPH* WPC80+** WPC80*
Degree of Hydrolysis (%) 32.0 ± 2 N/A N/A
Molecular Weight Profile (%)
>10 kD 4 ~80 82
5-10 kD 1 ~20 11
2-5 kD 4 <1 7
1-2 kD 9 <1 0
0.5-1 kD 17 <1 0
<0.5 kD 65 <1 0
Average Molecular Weight 1.569 kD >10 kD >10 kD
FIGURE 3. Molecular weight distributions/profiles of whey-containing 
supplements, by group . WPH = WHEY PROTEIN HYDROLYSATE; 
WPC80+ = HIGH LACTOFERRIN 80% WHEY PROTEIN 
CONCENTRATE; WPC80 = 80% WHEY PROTEIN CONCENTRATE. 
*Molecular weight as determined by size exclusion chromatography and 
reported by the raw material supplier. **Molecular weight of WPC as 
reported by Perea et al. [Enzyme Microb Technol  1993;15(5):418-23].
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Figure 4. 
PLA WPH WPC80+ WPC80
ENERGY (kcal) 176.430 166.244 162.581 156.591
FAT (g) 4.848 3.038 3.312 3.188
SATURATED FAT (g) 0.493 2.201 2.427 2.336
UNSATURATED FAT (g) 4.319 0.836 0.884 0.851
TRANS-FAT (g) 0.048 0.000 0.000 0.000
CHOLESTEROL (mg) 0.987 60.000 70.130 67.500
CARBOHYDRATE (g) 32.124 4.770 3.065 2.979
SUGARS (g) 31.442 4.510 2.996 2.910
FIBER (g) 0.630 0.000 0.000 0.000
PROTEIN (g) 0.597 30.053 30.001 30.001
CALCIUM (mg) 23.060 187.700 194.903 187.598
SODIUM (mg) 80.723 113.429 58.882 56.690
POTASSIUM (mg) 0.005 562.523 155.849 150.005
MAGNESIUM (mg) 0.004 22.516 19.485 18.754
PHOSPHOROUS (mg) 28.555 243.750 136.364 131.250
CHLORIDE (mg) 0.000 18.750 38.961 37.500
IRON (mg) 0.076 0.092 0.060 0.060
VITAMIN A (IU) 5.019 0.115 0.077 0.077
VITAMIN C (mg) 0.011 0.006 0.004 0.004
FIGURE 4. Nutritional comparison of supplements, by group  (units per single serving). 
PLA = PLACEBO; WPH = WHEY PROTEIN HYDROLYSATE; WPC80+ = HIGH 
LACTOFERRIN 80% WHEY PROTEIN CONCENTRATE; WPC80 = 80% WHEY PROTEIN 
CONCENTRATE. All subjects consumed two servings per day; one serving immediately 
pre- and post-exercise on training days (4d/wk), and two divided doses between meals on 
non-training days (3d/wk). All supplements were blinded for packaging, flavor, texture and 
appearance. Supplements were mixed with 8-10 fl ozs of water and consumed on an empty 
stomach.
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Figure 5. 
FIGURE 5. Relative training volume, by week . PLA = PLACEBO; WPH = WHEY PROTEIN 
HYDROLYSATE; WPC80+ = HIGH LACTOFERRIN 80% WHEY PROTEIN CONCENTRATE; 
WPC80 = 80% WHEY PROTEIN CONCENTRATE. Estimated average means adjusted for 
covariates: Training Status Ratio (PRE) and Average 8-wk Relative Protein Intake (g/kg/d). 
Main effects set at p ≤0.05. Relative training volume calculated as: [load (Kg) x reps x sets] / 
time (mins). No significant differences (p >0.05) were observed between groups for total or 
weekly volume. 
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Figure 6. 
6a.
6b.
6c.
FIGURE 6. Absolute and relative strength and anaerobic endurance changes from PRE to POST and for repeated 80RM . PLA = PLACEBO; WPH = WHEY PROTEIN HYDROLYSATE; WPC80+ = HIGH 
LACTOFERRIN 80% WHEY PROTEIN CONCENTRATE; WPC80 = 80% WHEY PROTEIN CONCENTRATE. 6a = Effects on Bench Press 1RM and 80RM; 6b = Effects on Hack Squat 1RM and 80RM; 6c = 
Effects on Repeated Hack Squat 80RM. 1RM BP = One-Repition Maximum Bench Press; 1RM HS = One-Repition Maximum Hack Squat; 80RM BP = Maximum Repitions to Failure at 80% of 1RM BP; 80RM HS = 
Maximum Repitions to Failure at 80% of 1RM HS; REPEATED 80RM HS = Repeated 80RM Hack Squat tests occurring 24 and 48 Hours after 80RMPOST Hack Squat. Estimated average means adjusted for covariates: 
Training Status Ratio (PRE), Total 8-wk Relative Training Volume (kg/min), and Average 8-wk Relative Protein Intake (g/kg/d). Main effects set at p ≤0.05.
*
Different from PRE (p ≤0.0125); 
†
Different from PLA 
(p ≤0.05); 
‡
Different from WPC80+ (p ≤0.05); 
§
Different from WPC80 (p ≤0.05); 
¶
24HR Different from POST  (p ≤0.0125).
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Figure 7. 
7a.
7b.
7c.
7d.
FIGURE 7. Individual responses for strength and anaerobic endurance changes from PRE to POST and for repeated 80RM . PLA = PLACEBO; WPH = WHEY PROTEIN 
HYDROLYSATE; WPC80+ = HIGH LACTOFERRIN 80% WHEY PROTEIN CONCENTRATE; WPC80 = 80% WHEY PROTEIN CONCENTRATE. 7a = Individual Responses on 1RM 
BP for PRE v POST; 7b = Individual Responses on 1RM HS for PRE v POST; 7c = Individual Responses on 80RM BP for PRE v POST; 7d = Individual Responses on 80RM HS for PRE v 
POST v 24HR v 48HR. 1RM BP = One-Repition Maximum Bench Press; 1RM HS = One-Repition Maximum Hack Squat; 80RM BP = Maximum Repitions to Failure at 80% of 1RM BP; 
80RM HS = Maximum Repitions to Failure at 80% of 1RM HS. Unadjusted subject responses used for individual response analyses, by group. Dashed line represents the unadjusted group 
mean change from PRE to POST.
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Figure 8. 
8a.
8b.
8c.
8d.
8e.
FIGURE 8. Absolute and relative body composition changes from PRE to POST . PLA = PLACEBO; WPH = 
WHEY PROTEIN HYDROLYSATE; WPC80+ = HIGH LACTOFERRIN 80% WHEY PROTEIN CONCENTRATE; 
WPC80 = 80% WHEY PROTEIN CONCENTRATE. BM = Body Mass; FM = Fat Mass; LBM = Lean Body Mass; 
%FAT = Percent Body Fat; TBMM = Total Body Muscle Mass. 8a = Effects on Body Mass; 8b = Effects on Fat 
Mass; 8c = Effects on Lean Body Mass; 8d = Effects on Percent Body Fat; 8e = Effects on Total Body Muscle 
Mass. Estimated average means adjusted for covariates: Training Status Ratio (PRE), Total 8-wk Relative Training 
Volume (kg/min), and Average 8-wk Relative Protein Intake (g/kg/d). Main effects set at p ≤0.05.*Different from 
PRE (p ≤0.0125); †Different from PLA (p ≤0.05); ‡Different from WPC80+ (p ≤0.05); §Different from WPC80 
(p ≤0.05).
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Figure 9. 
9a.
9b.
9c.
9d.
9e.
FIGURE 9. Individual responses for body composition changes from PRE to POST . PLA = PLACEBO; WPH = WHEY PROTEIN HYDROLYSATE; WPC80+ = HIGH 
LACTOFERRIN 80% WHEY PROTEIN CONCENTRATE; WPC80 = 80% WHEY PROTEIN CONCENTRATE. 9a = Individual Responses on BM for PRE v POST; 9b 
= Individual Responses on FM for PRE v POST; 9c = Individual Responses on LBM for PRE v POST; 9d = Individual Responses on %FAT for PRE v POST; 9e = 
Individual Responses on TBMM for PRE v POST. BM = Body Mass; FM = Fat Mass; LBM = Lean Body Mass; %FAT = Percent Body Fat; TBMM = Total Body Muscle 
Mass. Unadjusted subject responses used for individual response analyses, by group. Dashed line represents the unadjusted group mean change from PRE to POST.
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Figure 10. 
10a. 10b. 10c.
10d. 10e. 10f.
FIGURE 10. Changes in select blood measures from PRE to POST . PLA = PLACEBO; WPH = WHEY PROTEIN HYDROLYSATE; WPC80+ = HIGH LACTOFERRIN 80% WHEY PROTEIN 
CONCENTRATE; WPC80 = 80% WHEY PROTEIN CONCENTRATE. WBC = White Blood Cell count; BUN = Urea Nitrogen; BUN:CREATININE = Urea Nitrogen-to-Creatinine ratio; CK = Creatine 
Kinase. 10a = Effect on blood glucose from PRE to POST; 10b = Effect on creatinine from PRE to POST; 10c = Effect on white blood cell count from PRE to POST; 10d = Effect on urea nitrogen from 
PRE to POST; 10e = Effect on BUN:Creatinine ratio from PRE to POST; 10f = Effect on creatine kinase from PRE to POST. All blood draws under confirmed euhydrated state and after a 12-hour fast 
(water only). Estimated average means adjusted for covariates: Training Status Ratio (PRE), Total 8-wk Relative Training Volume (kg/min), Average 8-wk Relative Protein Intake (g/kg/d), and Blood 
Collection Time. Main effects set at p ≤0.05.
*
Different from PRE (p ≤0.0125); 
†
Different from PLA (p ≤0.05); 
‡
Different from WPC80+ (p ≤0.05); 
§
Different from WPC80 (p ≤0.05).
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Figure 11. 
FIGURE 11. Changes in 24-hour WBC and CK response to lower-body training from Week 1 to Week 8 . PLA = PLACEBO; WPH = WHEY PROTEIN HYDROLYSATE; WPC80+ = 
HIGH LACTOFERRIN 80% WHEY PROTEIN CONCENTRATE; WPC80 = 80% WHEY PROTEIN CONCENTRATE. WBC = White Blood Cell count; CK = Creatine Kinase. All blood 
draws took place after a 4-hour fast (water only). Estimated average means adjusted for covariates: Training Status Ratio (PRE), Total 8-wk Relative Training Volume (kg/min), Average 8-
wk Relative Protein Intake (g/kg/d), and Blood Collection Time. Main effects set at p ≤0.05.*Different from PRE (p ≤0.0125); †Different from PLA (p ≤0.05); ‡Different from WPC80+ 
(p ≤0.05); §Different from WPC80 (p ≤0.05).
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Figure 12. 
FIGURE 12. Changes in WBC and CK in response to repeated 80RM bouts . PLA = PLACEBO; WPH = WHEY 
PROTEIN HYDROLYSATE; WPC80+ = HIGH LACTOFERRIN 80% WHEY PROTEIN CONCENTRATE; WPC80 = 80% 
WHEY PROTEIN CONCENTRATE. WBC = White Blood Cell count; CK = Creatine Kinase. 1 = DAY 1 Pre-80RM blood 
draw (T1); 2 = DAY 1 Post-80RM blood draw (T2); 3 = DAY 2 Pre-80RM blood draw (T3); 4 = DAY 2 Post-80RM blood 
draw (T4); 5 = DAY 3 Pre-80RM blood draw (T5); 6 = DAY 3 Post-80RM blood draw (T6). Estimated average means 
adjusted for covariates: Training Status Ratio (PRE), Total 8-wk Relative Training Volume (kg/min), Average 8-wk 
Relative Protein Intake (g/kg/d), and Blood Collection Time. Main effects set at p ≤0.05. 1Different from T1 (p ≤0.0125); 
2
Different from T2 (p ≤0.0125); 3Different from T3 (p ≤0.0125); 4Different from T4 (p ≤0.0125); 5Different from T5 
(p ≤0.0125); †Different from PLA (p ≤0.05); ‡Different from WPC80+ (p ≤0.05); §Different from WPC80 (p ≤0.05).
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